Finex logo
Finex Intelligence

Market Signal Briefing

Real-time pulse of financial headlines curated from 2 premium feeds.

Last news saved at Mar 14, 13:46 31m ago Cron last ran Mar 14, 13:46 32m ago 2 sources live
Switch language
83,792 Stories ingested Auto-fetched market intel nonstop.
401 Distinct tickers Symbols referenced across the feed
stockne... Trending sources stocknewsapi • cryptonews
Hot tickers
BTC XRP ETH USDC $TRUMP SHIB
Surfacing from current coverage
Details Saved Published Title Source Tickers
2025-11-07 18:27 4mo ago
2025-11-07 13:16 4mo ago
Tech selloff breaks major S&P 500 support — but here's when stocks really unravel stocknewsapi
IVV SPLG SPXL SPY SSO UPRO VOO
HomeInvestingStocksLawrence G. McMillanLawrence G. McMillanTechnical indicators point to more weakness. Watch the VIX.Published: Nov. 7, 2025 at 1:16 p.m. ET

The S&P 500 SPX, after having gapped to all-time highs a little more than a week ago, is now in a modest (so far) corrective mode. SPX has now closed both of the gaps that were in place in late October and has closed below the first support level of 6,750. This is not a major breakdown of the chart at this point. SPX has merely pulled back to its rising 20-day moving average.

The next support level is the 6,500 to 6,550 level that has been tested and held several times. If that were to be broken, then a much more bearish outlook would be in store.

Partner CenterMost Popular
2025-11-07 18:27 4mo ago
2025-11-07 13:16 4mo ago
Applied Optoelectronics, Inc. (AAOI) Q3 2025 Earnings Call Transcript stocknewsapi
AAOI
Q3: 2025-11-06 Earnings SummaryEPS of -$0.09 misses by $0.00

 |

Revenue of

$70.60M

(8.37% Y/Y)

misses by $48.16M

Applied Optoelectronics, Inc. (AAOI) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST

Company Participants

Lindsay Savarese - Investor Relations
Chih-Hsiang Lin - Founder, Chairman, President & CEO
Stefan Murry - CFO & Chief Strategy Officer

Conference Call Participants

Simon Leopold - Raymond James & Associates, Inc., Research Division
George Notter - Wolfe Research, LLC
Michael Genovese - Rosenblatt Securities Inc., Research Division
Ryan Koontz - Needham & Company, LLC, Research Division
Timothy Savageaux - Northland Capital Markets, Research Division

Presentation

Operator

Good afternoon. I will be your conference operator today. At this time, I would like to welcome everyone to Applied Optoelectronics Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note, this call is being recorded.

I will now turn the call over to Lindsay Savarese, Investor Relations for Applied Optoelectronics. Ms. Savarese, you may begin.

Lindsay Savarese
Investor Relations

Thank you. I'm Lindsay Savarese, Investor Relations for Applied Optoelectronics. I'm pleased to welcome you to AOI's Third Quarter 2025 Financial Results Conference Call. After the market closed today, AOI issued a press release announcing its third quarter 2025 financial results and provided its outlook for the fourth quarter of 2025. The release is also available on the company's website at ao-inc.com. This call is being recorded and webcast live. A link to the recording can be found on the Investor Relations section of the AOI website and will be archived for 1 year.

Joining us on today's call is Dr. Thompson Lin, AOI's Founder, Chairman and CEO; and Dr. Stefan Murry, AOI's Chief Financial Officer and Chief Strategy Officer. Thompson will give an overview of AOI's Q3 results, and Stefan will provide financial details and the outlook for the fourth quarter of 2025. A question-and-answer session will follow our prepared remarks.

Before we begin, I would like to remind you to

Recommended For You
2025-11-07 18:27 4mo ago
2025-11-07 13:16 4mo ago
Puma Biotechnology, Inc. (PBYI) Q3 2025 Earnings Call Transcript stocknewsapi
PBYI
Q3: 2025-11-06 Earnings SummaryEPS of $0.21 beats by $0.12

 |

Revenue of

$54.50M

(-32.30% Y/Y)

beats by $3.50M

Puma Biotechnology, Inc. (PBYI) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST

Company Participants

Mariann Ohanesian - Senior Director of Investor Relations
Alan Auerbach - Founder, Chairman, President, CEO & Secretary
Heather Blaber
Roger Storms
Maximo F. Nougues - CFO & Principal Accounting Officer

Conference Call Participants

Marc Frahm - TD Cowen, Research Division

Presentation

Operator

Good afternoon. My name is Julian, and I will be your conference call operator today. [Operator Instructions] as a reminder, this call is being recorded. I would now like to turn the conference call over to Mariann Ohanesian, Senior Director of IR for Puma Biotechnology. Thank you. You may begin.

Mariann Ohanesian
Senior Director of Investor Relations

Thank you, Julian. Good afternoon, and welcome to Puma's conference call to discuss our earnings results for the third quarter of 2025. Joining me on the call today are Alan Auerbach, Chief Executive Officer, President and Chairman of the Board of Puma Biotechnology; Maximo Nougues, Chief Financial Officer; Heather Blaber, Senior Vice President of Marketing; and Roger Storms, Senior Vice President of Sales. After the close today, Puma issued a news release detailing earnings results for third quarter 2025. That news release, the slides that Roger will refer to and a webcast of this call are accessible via the homepage and Investors section of our website at pumabiotechnology.com. The webcast and presentation slides will be archived on our website and available for replay for the next 90 days.

Today's conference call will include statements about Puma's future expectations, plans and prospects that constitute forward-looking statements for purposes of federal securities laws. Such statements are subject to risks and uncertainties, and actual events and results may differ from those expressed in these forward-looking statements. For a full discussion of these risks and uncertainties, please review our periodic and current reports filed with the

Recommended For You
2025-11-07 18:27 4mo ago
2025-11-07 13:16 4mo ago
Main Street Capital Corporation (MAIN) Q3 2025 Earnings Call Transcript stocknewsapi
MAIN
Main Street Capital Corporation (MAIN) Q3 2025 Earnings Call November 7, 2025 10:00 AM EST

Company Participants

Dwayne Hyzak - CEO & Member of the Board
David Magdol - President & Chief Investment Officer
Ryan Nelson - CFO & Treasurer
Nicholas Meserve - Managing Director

Conference Call Participants

Zach Vaughan - Dennard Lascar Associates, LLC
Arren Cyganovich - Truist Securities, Inc., Research Division
Cory Johnson - UBS Investment Bank, Research Division

Presentation

Operator

Greetings, and welcome to the Main Street Capital Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Zach Vaughan. Thank you. You may begin.

Zach Vaughan
Dennard Lascar Associates, LLC

Thank you, operator, and good morning, everyone. Thank you for joining us for Main Street Capital Corporation's Third Quarter 2025 Earnings Conference Call. Joining me today with prepared comments are Dwayne Hyzak, Chief Executive Officer; David Magdol, President and Chief Investment Officer; and Ryan Nelson, Chief Financial Officer. Also participating in the Q&A portion of the call is Nick Meserve, Managing Director and Head of Main Street's Private Credit Investment Group.

Main Street issued a press release yesterday afternoon that details the company's third quarter financial and operating results. This document is available on the Investor Relations section of the company's website at mainstcapital.com. A replay of today's call will be available beginning an hour after the completion of the call and will remain available until November 14. Information on how to access the replay was included in yesterday's release. We also advise you that this conference call is being broadcast live through the Internet and can be accessed on the company's homepage.

Please note that information reported on this call speaks only as of today, November 7, 2025, and therefore, you are advised that time-sensitive information may

Recommended For You
2025-11-07 18:27 4mo ago
2025-11-07 13:16 4mo ago
Avino Silver & Gold Mines Ltd. (ASM:CA) Q3 2025 Earnings Call Transcript stocknewsapi
ASM
Avino Silver & Gold Mines Ltd. (ASM:CA) Q3 2025 Earnings Call November 7, 2025 11:00 AM EST

Company Participants

Jennifer North - Head of Investor Relations
David Wolfin - President, CEO & Director
Nathan Harte - Chief Financial Officer
Peter Latta - Vice President of Technical Services

Conference Call Participants

Jacob Sekelsky - Alliance Global Partners, Research Division
Heiko Ihle - H.C. Wainwright & Co, LLC, Research Division
Joseph Reagor - ROTH Capital Partners, LLC, Research Division
Chen Lin

Presentation

Operator

Welcome to the Avino Silver & Gold Mines Third Quarter 2025 Financial Results Conference Call and Webcast. [Operator Instructions] The conference is being recorded. [Operator Instructions] I would now like to turn the conference over to Jennifer North, Head of Investor Relations. Please go ahead.

Jennifer North
Head of Investor Relations

Thank you, operator. Good morning, everyone, and welcome to our Q3 earnings call and webcast. To join this webcast and conference call, there is a link in our news release of yesterday's date, which can be found on our website under News 2025. In addition, a link can be found on the homepage of the Avino website.

The full financial statements and MD&A are now available on our website under the Investors tab and then click on Financial Statements. In addition, the full statements are available on Avino's profile on SEDAR+ and on EDGAR.

Before we get started, I remind you to view our precautionary language regarding forward-looking statements and the risk factors pertaining to these statements. And note that certain statements made today on this call by the management team may include forward-looking information within the meaning of applicable securities laws.

Forward-looking statements are subject to known and unknown risks, uncertainties and other facts that may cause the actual results to be materially different than those expressed by or implied by such

Recommended For You
2025-11-07 18:27 4mo ago
2025-11-07 13:16 4mo ago
Sweetgreen: Disastrous Trends, But This Is A Value Stock With Infinite Kitchen Opportunity stocknewsapi
SG
Analyst’s Disclosure:I/we have a beneficial long position in the shares of SG either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-11-07 18:27 4mo ago
2025-11-07 13:18 4mo ago
PetVivo Sets Fiscal Second Quarter 2026 Conference Call for Friday, November 14, 2025 at 5:00 p.m. ET stocknewsapi
PETV
MINNEAPOLIS, MN, US, Nov. 07, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW) and its wholly-owned subsidiary Petvivo Animal Health, Inc., a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, will hold a conference call on Friday, November 14, 2025 at 5:00 p.m. Eastern time to discuss results for the fiscal second quarter ended September 30, 2025. The financial results will be issued in a press release prior to the call.

PetVivo management will host the presentation, followed by a question-and-answer period. The Fiscal Second Quarter 2026 conference call information is as follows:

Date: Friday, November 14, 2025
Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time)
Toll-free dial-in number: +1 669 444 9171
Conference ID: 87234562707
Passcode: 396948
Webcast (live and replay): Click Here

A replay of the webcast will be available through the same link following the conference call.

The conference call webcast replay will also be available via a link in the Investors section of the company’s website at petvivo.com/investors.

About PetVivo Holdings, Inc.

PetVivo Holdings Inc. (OTCQX: PETV; OTCID: PETVW), in cooperation with its wholly-owned subsidiary PetVivo Animal Health, Inc., is an emerging biomedical device company currently focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals. The Company's strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than more stringently regulated pharmaceuticals and biologics.

PetVivo has a robust pipeline of products for the treatment of animals and people. A portfolio of twelve patents and six trade secrets protect the Company's biomaterials, products, production processes and methods of use. The Company’s lead products SPRYNG® with OsteoCushion® technology, a veterinarian-administered, intra-articular injection for the management of lameness and other joint related afflictions, including osteoarthritis, in cats, dogs and horses, and PrecisePRP®, a first-in-class, off-the-shelf, platelet-rich plasma (PRP) product designed for use by veterinarians, are currently available for commercial sale.

Company Contact
John Lai, CEO
PetVivo Holdings, Inc.
Email Contact
Tel (952) 405-6216

Forward-Looking commercial Statements

The foregoing information regarding PetVivo Holdings, Inc. (the “Company”) may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation the Company’s proposed development and commercial timelines, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of uncertainties and risks that could significantly affect current plans. Risks concerning the Company’s business are described in detail in the Company’s Annual Report on Form 10-K for the year ended March 31, 2025 and other periodic and current reports filed with the Securities and Exchange Commission. The Company is under no obligation to, and expressly disclaims any such obligation to, update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
2025-11-07 18:27 4mo ago
2025-11-07 13:19 4mo ago
Even with all the flight cancellations, airline stocks are having a surprisingly good week. stocknewsapi
AAL DAL JBLU LUV UAL
HomeIndustriesAirlinesFor Wall Street, flight cancellations may not be the worst thing.Published: Nov. 7, 2025 at 1:19 p.m. ET

As thousands of would-be air-travel passengers scramble to find alternatives to their canceled or delayed flights, Wall Street is cheering all the way to the bank.

Maybe not exactly cheering, as the risk to U.S. airlines’ bottom lines is real. If the U.S. government shutdown continues into Thanksgiving week — historically the busiest for travel — “disaster” awaits. And the stakes are higher this year: Thanksgiving bookings are up about 2% relative to Thanksgiving 2024, according to aviation-analytics company Cirium.

Partner CenterMost Popular
2025-11-07 18:27 4mo ago
2025-11-07 13:20 4mo ago
Big Tech's AI spending spree: Smart long-term bet or short-term risk? stocknewsapi
AAPL AMZN GOOGL MSFT
CNBC's Paulina Likos and Zev Fima break down big tech's massive artificial intelligence spending spree
2025-11-07 18:27 4mo ago
2025-11-07 13:21 4mo ago
KBR 11-DAY DEADLINE ALERT: KBR, Inc. (KBR) Cuts 2025 Revenue Due to TRANSCOM Termination, Securities Class Action Looms – Hagens Berman stocknewsapi
KBR
SAN FRANCISCO, Nov. 07, 2025 (GLOBE NEWSWIRE) -- A pending class-action lawsuit targeting KBR, Inc. (NYSE: KBR) alleges that the company made misleading statements to investors in the weeks leading up to the abrupt cancellation of a major military contract which negatively impacted the company’s business prospects. The lawsuit seeks to represent investors who purchased or otherwise acquired KBR securities between May 6, 2025 and June 19, 2025.

National shareholders rights firm Hagens Berman urges KBR investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.

Class Period: May 6, 2025 – June 19, 2025
Lead Plaintiff Deadline: Nov. 18, 2025
Visit: www.hbsslaw.com/investor-fraud/kbr
Contact the Firm Now: [email protected] | 844-916-0895

KBR, Inc. (KBR) Securities Class Action:

The legal action claims that KBR executives provided a falsely optimistic outlook on a crucial partnership just as it was on the verge of collapse.

The litigation stems from the Department of Defense U.S. Transportation Command (TRANSCOM) canceling its global household goods contract with HomeSafe Alliance LLC, a joint venture led by KBR. The decision, announced on June 20, 2025, caused KBR shares to fall over 7% as investors reacted to the loss of a contract valued at up to $20 billion over a potential nine-year term.

The suit highlights a key discrepancy: on May 6, 2025, during its Q1 earnings call, KBR assured investors that the HomeSafe partnership was "strong" and "excellent" and that the company was "very confident in the future of this program." Importantly, the company also assured investors that the HomeSafe JV would contribute a mid-point revenue contribution of about $400 million for 2025.

However, just weeks later, on June 19, 2025, HomeSafe disclosed that TRANSCOM had terminated the contract for cause. The termination reportedly came after months of operational issues, including chronic delays, missed pickups, and a rise in complaints about damaged goods. The complaint alleges that KBR was aware of TRANSCOM’s material concerns but chose to conceal them from investors. The lawsuit argues that this misrepresentation led to the significant financial losses suffered by shareholders.

KBR Revises Revenue Guidance Downward After TRANSCOM Partnership Termination

The adverse financial impact of TRANSCOM’s termination of the “strong” and “excellent” partnership became clear after the class period, when on July 31, 2025, KBR reported its Q2 2025 financial results. The company officially revised its low-end 2025 revenue guidance downward by about $900 million (-9%), in large part due to removal of the HomeSafe JV revenue contribution. During the earnings call that day, KBR management said, "we acknowledge there were operational challenges."

“We’re focused on whether KBR may have intentionally misled investors about the true status of the relationship with TRANSCOM and the contract,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you invested in KBR and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses now.

If you’d like more information and answers to frequently asked questions about the KBR case and our investigation, read more.

Whistleblowers: Persons with non-public information regarding KBR should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman
Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

Contact:
Reed Kathrein, 844-916-0895
2025-11-07 18:27 4mo ago
2025-11-07 13:21 4mo ago
Will Steven Madden (SHOO) Gain on Rising Earnings Estimates? stocknewsapi
SHOO
Investors might want to bet on Steven Madden (SHOO - Free Report) , as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this trend might continue with its still improving earnings outlook.

The upward trend in estimate revisions for this footwear and accessories retailer reflects growing optimism of analysts on its earnings prospects, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- is principally built on this insight.

The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.

For Steven Madden, strong agreement among the covering analysts in revising earnings estimates upward has resulted in meaningful improvement in consensus estimates for the next quarter and full year.

The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:

12 Month EPS

Current-Quarter Estimate RevisionsFor the current quarter, the company is expected to earn $0.27 per share, which is a change of -50.9% from the year-ago reported number.

Over the last 30 days, one estimate has moved higher for Steven Madden compared to no negative revisions. As a result, the Zacks Consensus Estimate has increased 83.16%.

Current-Year Estimate RevisionsThe company is expected to earn $1.60 per share for the full year, which represents a change of -40.1% from the prior-year number.

There has been an encouraging trend in estimate revisions for the current year as well. Over the past month, two estimates have moved up for Steven Madden versus no negative revisions. This has pushed the consensus estimate 10.01% higher.

Favorable Zacks RankThe promising estimate revisions have helped Steven Madden earn a Zacks Rank #1 (Strong Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision.

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.

Bottom LineInvestors have been betting on Steven Madden because of its solid estimate revisions, as evident from the stock's 12.9% gain over the past four weeks. As its earnings growth prospects might push the stock higher, you may consider adding it to your portfolio right away.
2025-11-07 18:27 4mo ago
2025-11-07 13:21 4mo ago
Can Kennametal (KMT) Run Higher on Rising Earnings Estimates? stocknewsapi
KMT
Kennametal (KMT - Free Report) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts are still raising their earnings estimates for the company.

Analysts' growing optimism on the earnings prospects of this engineered products maker is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- has this insight at its core.

The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.

Consensus earnings estimates for the next quarter and full year have moved considerably higher for Kennametal, as there has been strong agreement among the covering analysts in raising estimates.

The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:

12 Month EPS

Current-Quarter Estimate RevisionsFor the current quarter, the company is expected to earn $0.27 per share, which is a change of +8.0% from the year-ago reported number.

Over the last 30 days, one estimate has moved higher for Kennametal compared to no negative revisions. As a result, the Zacks Consensus Estimate has increased 40%.

Current-Year Estimate RevisionsFor the full year, the company is expected to earn $1.13 per share, representing a year-over-year change of -15.7%.

In terms of estimate revisions, the trend for the current year also appears quite encouraging for Kennametal. Over the past month, one estimate has moved higher compared to no negative revisions, helping the consensus estimate increase 38.89%.

Favorable Zacks RankThanks to promising estimate revisions, Kennametal currently carries a Zacks Rank #2 (Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision.

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.

Bottom LineWhile strong estimate revisions for Kennametal have attracted decent investments and pushed the stock 22.8% higher over the past four weeks, further upside may still be left in the stock. So, you may consider adding it to your portfolio right away.
2025-11-07 18:27 4mo ago
2025-11-07 13:21 4mo ago
Earnings Estimates Moving Higher for Sanmina (SANM): Time to Buy? stocknewsapi
SANM
Investors might want to bet on Sanmina (SANM - Free Report) , as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this trend might continue with its still improving earnings outlook.

Analysts' growing optimism on the earnings prospects of this electronics manufacturing services company is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- is principally built on this insight.

The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.

Consensus earnings estimates for the next quarter and full year have moved considerably higher for Sanmina, as there has been strong agreement among the covering analysts in raising estimates.

The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:

12 Month EPS

Current-Quarter Estimate RevisionsThe company is expected to earn $2.15 per share for the current quarter, which represents a year-over-year change of +49.3%.

Over the last 30 days, the Zacks Consensus Estimate for Sanmina has increased 22.76% because one estimate has moved higher compared to no negative revisions.

Current-Year Estimate RevisionsThe company is expected to earn $9.64 per share for the full year, which represents a change of +59.6% from the prior-year number.

The revisions trend for the current year also appears quite promising for Sanmina, with two estimates moving higher over the past month compared to no negative revisions. The consensus estimate has also received a boost over this time frame, increasing 32.42%.

Favorable Zacks RankThe promising estimate revisions have helped Sanmina earn a Zacks Rank #1 (Strong Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision.

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.

Bottom LineInvestors have been betting on Sanmina because of its solid estimate revisions, as evident from the stock's 32.3% gain over the past four weeks. As its earnings growth prospects might push the stock higher, you may consider adding it to your portfolio right away.
2025-11-07 18:27 4mo ago
2025-11-07 13:21 4mo ago
Can Aurinia (AUPH) Run Higher on Rising Earnings Estimates? stocknewsapi
AUPH
Aurinia Pharmaceuticals (AUPH - Free Report) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts are still raising their earnings estimates for the company.

Analysts' growing optimism on the earnings prospects of this biotechnology company is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- is principally built on this insight.

The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.

Consensus earnings estimates for the next quarter and full year have moved considerably higher for Aurinia Pharmaceuticals, as there has been strong agreement among the covering analysts in raising estimates.

The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:

12 Month EPS

Current-Quarter Estimate RevisionsThe earnings estimate of $0.21 per share for the current quarter represents a change of +133.3% from the number reported a year ago.

The Zacks Consensus Estimate for Aurinia has increased 21.57% over the last 30 days, as two estimates have gone higher compared to no negative revisions.

Current-Year Estimate RevisionsFor the full year, the earnings estimate of $0.78 per share represents a change of +1,850.0% from the year-ago number.

In terms of estimate revisions, the trend for the current year also appears quite encouraging for Aurinia. Over the past month, four estimates have moved higher compared to no negative revisions, helping the consensus estimate increase 20.34%.

Favorable Zacks RankThanks to promising estimate revisions, Aurinia currently carries a Zacks Rank #2 (Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision.

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.

Bottom LineAurinia shares have added 20.1% over the past four weeks, suggesting that investors are betting on its impressive estimate revisions. So, you may consider adding it to your portfolio right away to benefit from its earnings growth prospects.
2025-11-07 18:27 4mo ago
2025-11-07 13:21 4mo ago
Can RBB (RBB) Run Higher on Rising Earnings Estimates? stocknewsapi
RBB
RBB (RBB - Free Report) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.

Analysts' growing optimism on the earnings prospects of this bank holding company is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. This insight is at the core of our stock rating tool -- the Zacks Rank.

The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.

Consensus earnings estimates for the next quarter and full year have moved considerably higher for RBB, as there has been strong agreement among the covering analysts in raising estimates.

The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:

12 Month EPS

Current-Quarter Estimate RevisionsFor the current quarter, the company is expected to earn $0.49 per share, which is a change of +96.0% from the year-ago reported number.

Over the last 30 days, the Zacks Consensus Estimate for RBB has increased 11.36% because five estimates have moved higher compared to no negative revisions.

Current-Year Estimate RevisionsFor the full year, the earnings estimate of $1.73 per share represents a change of +17.7% from the year-ago number.

The revisions trend for the current year also appears quite promising for RBB, with five estimates moving higher over the past month compared to no negative revisions. The consensus estimate has also received a boost over this time frame, increasing 15.29%.

Favorable Zacks RankThanks to promising estimate revisions, RBB currently carries a Zacks Rank #1 (Strong Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision.

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.

Bottom LineRBB shares have added 6.1% over the past four weeks, suggesting that investors are betting on its impressive estimate revisions. So, you may consider adding it to your portfolio right away to benefit from its earnings growth prospects.
2025-11-07 18:27 4mo ago
2025-11-07 13:21 4mo ago
Surging Earnings Estimates Signal Upside for Celestica (CLS) Stock stocknewsapi
CLS
Celestica (CLS - Free Report) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.

The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this electronics manufacturing services company, should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- is principally built on this insight.

The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.

Consensus earnings estimates for the next quarter and full year have moved considerably higher for Celestica, as there has been strong agreement among the covering analysts in raising estimates.

The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:

12 Month EPS

Current-Quarter Estimate RevisionsThe earnings estimate of $1.73 per share for the current quarter represents a change of +55.9% from the number reported a year ago.

Over the last 30 days, three estimates have moved higher for Celestica compared to no negative revisions. As a result, the Zacks Consensus Estimate has increased 17.03%.

Current-Year Estimate RevisionsFor the full year, the earnings estimate of $5.90 per share represents a change of +52.1% from the year-ago number.

The revisions trend for the current year also appears quite promising for Celestica, with three estimates moving higher over the past month compared to no negative revisions. The consensus estimate has also received a boost over this time frame, increasing 7.9%.

Favorable Zacks RankThe promising estimate revisions have helped Celestica earn a Zacks Rank #1 (Strong Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision.

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.

Bottom LineInvestors have been betting on Celestica because of its solid estimate revisions, as evident from the stock's 31.2% gain over the past four weeks. As its earnings growth prospects might push the stock higher, you may consider adding it to your portfolio right away.
2025-11-07 18:27 4mo ago
2025-11-07 13:21 4mo ago
Microchip Q2 Earnings Beat Estimates, Sales Down Y/Y, Shares Drop stocknewsapi
MCHP
Key Takeaways Microchip posted fiscal Q2 earnings of 35 cents per share, down 24% year over year but above estimates.Fiscal Q2 revenues of $1.14B fell 2% year over year but rose 6% sequentially.
Microchip projects Q3 sales near $1.13B and EPS of 34-40 cents, with operating margin up to 26.9%.

Microchip Technology (MCHP - Free Report) reported second-quarter fiscal 2026 non-GAAP earnings of 35 cents per share, which beat the Zacks Consensus Estimate by 6.06% but fell 24% year over year.

Net sales of $1.14 billion decreased 2% year over year and beat the Zacks Consensus Estimate by 0.75%. Sequentially, revenues increased 6%.

Following the fiscal second-quarter results, Microchip shares were down more than 9% at the time of writing this article. MCHP shares have inched up 3.5%, outperforming the broader Zacks Computer and Technology sector’s appreciation of 27.1% year to date.

Microchip’s Segmental DetailsSales from Mixed-signal Microcontroller, Analog and Other accounted for 51.3%, 28.2% and 20.6% of net sales, respectively. Microcontroller grew 9.7% sequentially with strong contribution from 32-bit MCU, while analog business sales increased 1.7% sequentially.

In terms of channel, direct sales accounted for 55%, while 45% came from distribution.

Geographically, revenues from the Americas, Europe and Asia contributed 29.7%, 19.7% and 50.6% to net sales, respectively. Net sales grew in the Americas and Asia, while it was flat in Europe.

MCHP’s Operating ResultsNon-GAAP gross margin contracted 290 basis points (bps) on a year-over-year basis to 56.7% but expanded 236 bps sequentially. Product gross margin was 67.4% driven by a rich product mix of data center products. Underutilization in MCHP’s factories in the reported quarter was $51 million.

Non-GAAP research & development expenses, as a percentage of net sales, increased 170 bps year over year to 20.1%. Non-GAAP selling, general & administrative expenses, as a percentage of net sales, climbed 40 bps year over year to 12.3%.

Non-GAAP operating expenses, as a percentage of net sales, were 32.4% compared with 30.3% reported in the year-ago quarter.

Consequently, the non-GAAP operating margin declined to 24.3% compared with 29.3% reported in the year-ago quarter. Sequentially, operating margin expanded 364 bps.

Microchip’s Balance Sheet & Cash FlowAs of Sept. 30, 2025, cash and short-term investments totaled $236.8 million compared with $566.5 million as of June 30. As of Sept. 30, 2025, total debt (long-term plus current portion) was $5.38 billion compared with $5.46 billion as of June.

Inventory at the end of September 2025 was 199 days, down from 214 days at the end of June 2025. Distribution inventory days were reduced by a couple of days to 27 days.

For the fiscal second quarter, cash flow from operating activities was $88.1 million compared with $275.6 million in the previous quarter. Free cash flow was $38.3 million compared with $257.7 million in the previous quarter.

Microchip returned roughly $245.8 million to shareholders through dividends in the fiscal second quarter. The company announced a quarterly dividend of 45.5 cents per share.

MCHP Offers Positive Q3 GuidanceMicrochip expects net sales to be $1.129 billion (+/-$20 million) at mid-point for the third quarter of fiscal 2026, which reflects roughly 1% sequential decline.

The company expects inventory at the end of the September quarter to be between 195 and 200 days.

Non-GAAP earnings are anticipated between 34 cents per share and 40 cents per share.

Non-GAAP gross margin is anticipated between 57.2% and 59.2%. Non-GAAP operating expenses are projected to be 32.3-32.7%. Non-GAAP operating margin is anticipated to be 24.5-26.9%.

Zacks Rank & Upcoming Earnings to ConsiderMicrochip currently carries a Zacks Rank #3 (Hold).

Analog Devices (ADI - Free Report) , CoreWeave (CRWV - Free Report) and Exodus Movement (EXOD - Free Report) are some better-ranked stocks worth considering in the broader Zacks Computer and Technology sector. While Exodus Movement currently sports a Zacks Rank #1, CoreWeave and Analog Devices carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.

Exodus Movement shares are down 27.8% year to date. Exodus Movement is set to report its third-quarter 2025 results on Nov. 10.

Analog Devices shares have appreciated 9.6% year to date. Analog Devices is set to report its fourth-quarter fiscal 2025 results on Nov. 25.

CoreWeave shares have jumped 167.3% year to date. CoreWeave is set to report its third-quarter 2025 results on Nov. 10.
2025-11-07 18:27 4mo ago
2025-11-07 13:25 4mo ago
SMX: The $1 Trillion Opportunity Hidden in Every Material stocknewsapi
SMX
NEW YORK, NY / ACCESS Newswire / November 7, 2025 / SMX (NASDAQ:SMX) isn't in the sustainability business. It's in the truth business.
2025-11-07 17:27 4mo ago
2025-11-07 12:06 4mo ago
Ready Capital Corporation (RC) Q3 2025 Earnings Call Transcript stocknewsapi
RC RCC RCD
Q3: 2025-11-06 Earnings SummaryEPS of -$0.94 misses by $0.70

 |

Revenue of

$137.49M

(-39.31% Y/Y)

misses by $10.41M

Ready Capital Corporation (RC) Q3 2025 Earnings Call November 7, 2025 8:30 AM EST

Company Participants

Andrew Ahlborn - CFO & Secretary
Thomas Capasse - Chairman, CEO & Chief Investment Officer

Conference Call Participants

Douglas Harter - UBS Investment Bank, Research Division
Jade Rahmani - Keefe, Bruyette, & Woods, Inc., Research Division
Christopher Nolan - Ladenburg Thalmann & Co. Inc., Research Division

Presentation

Operator

Greetings, and welcome to the Ready Capital Third Quarter 2025 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Andrew Ahlborn, Chief Financial Officer. Thank you. You may begin.

Andrew Ahlborn
CFO & Secretary

Thank you, operator, and good morning to those of you on the call. Some of our comments today will be forward-looking statements within the meaning of the federal securities laws. Such statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from what we expect. Therefore, you should exercise caution in interpreting and relying on them. We refer you to our SEC filings for a more detailed discussion of the risks that could impact our future operating results and financial condition.

During the call, we will discuss our non-GAAP measures, which we believe can be useful in evaluating the company's operating performance. These measures should not be considered in isolation or as a substitute for our financial results prepared in accordance with GAAP. A reconciliation of these measures to the most directly comparable GAAP measure is available in our third quarter 2025 earnings release and our supplemental information, which can be found in the Investors section of the Ready Capital website. In addition to Tom and myself on today's call, we are also joined by Adam Zausmer, Ready Capital's Chief Credit Officer.

I will now

Recommended For You
2025-11-07 17:27 4mo ago
2025-11-07 12:07 4mo ago
Columbia Seligman Premium Technology Growth Fund Announces a Fourth Quarter Distribution stocknewsapi
STK
BOSTON--(BUSINESS WIRE)--Today, Columbia Seligman Premium Technology Growth Fund, Inc. (NYSE: STK) (the Fund) declared a fourth quarter distribution, that is beyond its typical quarterly managed distribution, in the total amount of $1.3280 per share of common stock (which includes the Fund’s typical quarterly $0.4625 per share distribution). A federal excise tax of 4% applies to funds that do not distribute substantially all of their annual income (including net gains) before the end of their fiscal year. The Fund’s income for the 2025 fiscal year exceeds the amounts previously distributed pursuant to the Fund’s quarterly managed distribution policy. The Fund is including this excess income – beyond the Fund’s typical quarterly distribution – in the fourth quarter distribution so that it will not incur the 4% federal excise tax in 2025.

The distribution will be paid on December 9, 2025 (the Payment Date) to stockholders of record on November 17, 2025 (the Record Date). The ex-dividend date is November 17, 2025. Because all of the distribution is expected to be a special capital gain distribution, it will automatically be paid in stock except that any Record Date stockholder may elect to receive the distribution in cash by contacting, as applicable, their financial advisor (for shareholders who hold shares through a financial intermediary, such as a broker-dealer) or the Fund’s stockholder servicing agent, Equiniti Trust Company, LLC, whose contact information appears below (for shareholders who hold shares directly with the Fund), by 5 pm Eastern Time on December 2, 2025. It is anticipated that the Fund will make its next distribution under its managed distribution policy in the month of February.

The following table sets forth the estimated breakdown of the distribution noted above, on a per share basis, from the following sources: net investment income; net realized short-term capital gains; net realized long-term capital gains; and return of capital or other capital source.

Breakdown of Distribution

Sources

%

US Dollar

Net Investment Income

0.00%

$0.0000

Net Realized Short-Term Capital Gains

0.00%

$0.0000

Net Realized Long-Term Capital Gains

100.00%

$1.3280

Return of Capital or other Capital Source

0.00%

$0.0000

Total

100.00%

$1.3280

The following table sets forth the estimated breakdown, on a per share basis, of all distributions made by the Fund during the year-to-date period ended on the Payment Date of the above distributions (includes the distribution payment noted in the table above) from the following sources: net investment income; net realized short-term capital gains; net realized long-term capital gains; and return of capital or other capital source.

Breakdown of All Distributions Paid Through Year-To-Date Period Ended on the Payment Date of the Current Distribution

Sources

%

US Dollar

Net Investment Income

0.00%

$0.0000

Net Realized Short-Term Capital Gains

7.67%

$0.2082

Net Realized Long-Term Capital Gains

92.33%

$2.5073

Return of Capital or other Capital Source

0.00%

$0.0000

Total

100.00%

$2.7155

In certain years since the Fund’s inception, the Fund has distributed more than its income and net realized capital gains, which has resulted in Fund distributions substantially consisting of return of capital or other capital source. A return of capital may occur, for example, when some or all of the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund’s investment performance and should not be confused with “yield” or “income.” As of the payment date of the current distribution, all Fund distributions paid in 2025 (as estimated by the Fund based on current information) are from the earnings and profits of the Fund and not a return of capital. This could change during the remainder of the year, as further described below.

The amounts, sources and percentage breakdown of the distributions reported above are only estimates and are not being provided for, and should not be used for, tax reporting purposes. The actual amounts, sources and percentage breakdown of the distribution for tax reporting purposes, which may include return of capital, will depend upon the Fund’s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations.

The following table sets forth (i) the average annual total return of a share of the Fund’s common stock at net asset value (NAV) for the 5-year period ended October 31, 2025 and (ii) the Fund’s annualized distribution rate for the year-to-date period ended October 31, 2025, expressed as a percentage of the NAV price of a share of the Fund’s common stock at October 31, 2025.

The following table sets forth (i) the cumulative total return (at NAV) of a share of the Fund’s common stock for the year-to-date period ended October 31, 2025, and (ii) the Fund’s distribution rate, for the same period, expressed as a percentage of the NAV price of a share of the Fund’s common stock at October 31, 2025

You should not draw any conclusions about the Fund’s investment performance from the amount of the distributions noted in the tables above or from the terms of the Fund’s distribution policy.

The Fund or your financial professional will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions on your US federal income tax return. For tax purposes, the Fund is required to report unrealized gains or losses on certain non-US investments as ordinary income or loss, respectively. Accordingly, the amount of the Fund’s total distributions that will be taxable as ordinary income may be different than the amount of the distributions from net investment income reported above.

The Board may change the Fund’s distribution policy and the amount or timing of the distributions, based on a number of factors, including, but not limited to, the amount of the Fund’s undistributed net investment income and net short- and long-term capital gains and historical and projected net investment income and net short- and long-term capital gains.

The Fund is a closed-end investment company that trades on the New York Stock Exchange.

Past performance does not guarantee future results.

Important Disclosures:

You should consider the investment objectives, risks, charges, and expenses of the Fund carefully before investing. A prospectus containing information about the Fund (including its investment objectives, risks, charges, expenses, and other information) may be obtained by contacting your financial advisor or the Fund’s transfer agent at 866-666-1532 or visiting columbiathreadneedleus.com. The prospectus can also be found on the Securities and Exchange Commission’s EDGAR database. The prospectus should be read carefully before investing in the Fund. There is no guarantee that the Fund’s investment goals/objectives will be met or that distributions will be made, and you could lose money.

The Fund expects to receive all or some of its current income and gains from the following sources: (i) dividends received by the Fund that are paid on the equity and equity-related securities in its portfolio; and (ii) capital gains (short-term and long-term) from option premiums and the sale of portfolio securities. It is possible that the Fund’s distributions will at times exceed the earnings and profits of the Fund and therefore all or a portion of such distributions may constitute a return of capital as described below. A return of capital is a return of your original investment. A return of capital distribution does not necessarily reflect the Fund’s investment performance and should not be confused with “yield” or “income.” You should not draw any conclusions about the Fund’s investment performance from the amount of this distribution or from the Fund’s distribution policy.

Distributions that qualify as a return of capital are a return of some or all of your original investment in the Fund. A return of capital reduces a stockholder’s tax basis in his or her shares. Once the tax basis in your shares has been reduced to zero, any further return of capital may be taxable as capital gain. Shareholders should consult their tax advisor or tax attorney for proper treatment.

Distributions may be variable, and the Fund’s distribution rate will depend on a number of factors, including the net earnings on the Fund’s portfolio investments and the rate at which such net earnings change as a result of changes in the timing of, and rates at which, the Fund receives income from the sources noted above. As portfolio and market conditions change, the rate of distributions on the shares and the Fund’s distribution policy could change.

Market risk may affect a single issuer, sector of the economy, industry or the market as a whole. The products of technology companies may be subject to severe competition and rapid obsolescence, and their stocks may be subject to greater price fluctuations. Investments in small- and mid-cap companies involve risks and volatility greater than investments in larger, more established companies. Foreign investments subject the fund to risks, including political, economic, market, social and others within a particular country, as well as to currency instabilities and less stringent financial and accounting standards generally applicable to U.S. issuers. As a non-diversified fund, fewer investments could have a greater effect on performance. The Fund’s derivatives strategies may not be successful and could result in significant Fund losses.

The Fund should only be considered as one element of a complete investment program. An investment in the Fund should be considered speculative. The Fund's investment policy of investing in technology and technology-related companies and writing call options involves a high degree of risk.

There is no assurance that the Fund will meet its investment objectives or that distributions will be made. You could lose some or all of your investment. In addition, closed-end funds frequently trade at a discount to their net asset values, which may increase your risk of loss.

The Fund is not insured by the FDIC, NCUA or any federal agency, is not a deposit or obligation of, or guaranteed by any financial institution, and involves investment risks including possible loss of principal and fluctuation in value.

Columbia Threadneedle Investments (Columbia Threadneedle) is the global brand name of the Columbia and Threadneedle group of companies.

Columbia Seligman Premium Technology Growth Fund is managed by Columbia Management Investment Advisers, LLC.

If your Fund shares are held directly by the Fund’s stockholder servicing agent and you wish to elect a cash distribution (in lieu of a distribution paid in stock) or otherwise want more information about the Fund, call Equiniti Trust Company, LLC, the Fund’s stockholder servicing agent, at 800-937-5449. Customer Service Representatives are available to answer your questions Monday through Friday from 8 a.m. to 8 p.m. Eastern time. Equiniti Trust Company, LLC, which is located at 28 Liberty Street, Floor 53, New York, New York, 10005, is not affiliated with the Fund, Columbia Management Investment Advisers, LLC.

If your shares are not held through Equiniti Trust Company, LLC and you wish to elect a cash distribution (in lieu of a distribution paid in stock) or otherwise want more information about the Fund, please call your financial advisor or other financial intermediary through which you own Fund shares.

© 2025 Columbia Threadneedle. All rights reserved.

columbiathreadneedleus.com

Adtrax: CTNA8573215.1-
2025-11-07 17:27 4mo ago
2025-11-07 12:09 4mo ago
Stacy: EXPE Shows Travel Boom Intact, Discretionary Spend "Reckoning" to be Seen stocknewsapi
EXPE
Frances Stacy considers Expedia's (EXPE) earnings very strong in the current economic environment. She and many other investors were surprised to see the company beat Airbnb (ABNB) and Booking (BKNG) in room reservations.
2025-11-07 17:27 4mo ago
2025-11-07 12:10 4mo ago
SNPS Investors Have Opportunity to Lead Synopsys, Inc. Securities Fraud Lawsuit with the Schall Law Firm stocknewsapi
SNPS
LOS ANGELES, Nov. 07, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Synopsys, Inc. (“Synopsys” or “the Company”) (NASDAQ: SNPS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between December 4, 2024 and September 9, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before December 30, 2025.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. The extent Synopsys increased its focus on AI customers negatively impacted its Design IP business. Due to these decisions by the Company, "certain road map and resource decisions" were unlikely to "yield their intended results.” Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Synopsys, investors suffered damages.

Join the case to recover your losses

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.        

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

SOURCE:

The Schall Law Firm
2025-11-07 17:27 4mo ago
2025-11-07 12:11 4mo ago
Fiserv to Participate in Upcoming Investor Conferences stocknewsapi
FI FISV
-

MILWAUKEE--(BUSINESS WIRE)--Fiserv, Inc. (NYSE: FI), a leading global provider of payments and financial services technology, today announced its participation in the following investor conferences.

Mike Lyons, CEO, and Paul Todd, CFO, will participate in the following conferences:

KBW Fintech Payments Conference

12:25 p.m. ET on November 12

UBS Global Technology and AI Conference

1:35 p.m. ET on December 1

Live webcasts and archived replays will be available on the investor relations section of the Fiserv website at investors.fiserv.com.

About Fiserv

Fiserv, Inc. (NYSE: FI), a Fortune 500 company, moves more than money. As a global leader in payments and financial technology, the company helps clients achieve best-in-class results through a commitment to innovation and excellence in areas including account processing and digital banking solutions; card issuer processing and network services; payments; e-commerce; merchant acquiring and processing; and Clover®, the world’s smartest point-of-sale system and business management platform. Fiserv is a member of the S&P 500® Index, one of TIME Magazine’s Most Influential Companies™ and one of Fortune® World’s Most Admired Companies™. Visit fiserv.com and follow on social media for more information and the latest company news.

FI-G

More News From Fiserv, Inc.

Back to Newsroom
2025-11-07 17:27 4mo ago
2025-11-07 12:11 4mo ago
EnerSys' Q2 Earnings & Sales Beat Estimates, Increase Year Over Year stocknewsapi
ENS
Key Takeaways EnerSys' Q2 adjusted EPS of $2.56 beat estimates and rose 20.6% year over year.Net sales climbed 7.7% to $951.3M, driven by data centers and the Bren-Tronics acquisition.ENS guides Q3 EPS of $2.71-$2.81 on $920-$960M sales, signaling continued earnings momentum.
EnerSys (ENS - Free Report) reported second-quarter fiscal 2026 (ended Sept. 28, 2025) adjusted earnings of $2.56 per share, which surpassed the Zacks Consensus Estimate of $2.08. The bottom line increased 20.6% year over year.

EnerSys’ net sales of $951.3 million beat the consensus estimate of $928 million. The top line increased 7.7% year over year, driven by strength in data center and communications markets, along with the Bren-Tronics acquisition. While acquisitions boosted sales by 1%, pricing had a positive impact of 3%. Foreign currency translation had a positive impact of 1%. Organic sales increased 3%.

Segmental DiscussionThe Energy Systems segment’s sales (accounting for 45.7% of total sales) were $435 million, up 14% year over year. The Zacks Consensus Estimate for segmental net sales was $394 million. Net sales increased due to growth in data centers and a continued recovery in the U.S. Communications market. While volume increased 10%, price/mix and foreign currency translation had positive impacts of 3% and 1%, respectively, on sales.

The Motive Power segment generated net sales of $360 million (accounting for 37.9% of total sales), down 2% year over year. The consensus estimate for segmental net sales was $356 million. Volume declined 6% in the quarter, and foreign currency translation had a favorable impact of 1% on sales.

The Specialty segment’s sales were $157 million (accounting for 16.4% of total sales), up 16% year over year. The consensus estimate was $137 million. Results benefited from the strong contribution of the Bren-Tronics acquisition. While volume increased 7%, acquisitions had a positive impact of 7% on sales. Foreign currency translation positively impacted sales by 1%.

ENS’ Margin ProfileEnerSys' cost of sales increased 6.7% year over year to $674 million. Gross profit increased 10% year over year to $277.2 million while the gross margin was up 40 basis points (bps) to 29.1%.

Operating expenses were up 9% year over year to $164.1 million. Operating earnings decreased 7.4% to $92.0 million. The operating margin decreased 150 bps year over year to 9.7%.

Balance Sheet and Cash FlowAt the end of the fiscal second quarter, EnerSys had cash and cash equivalents of $388.6 million compared with $343.1 million at the end of fiscal 2025. Long-term debt (net of unamortized debt issuance costs) was $1.18 billion compared with $1.08 billion at fiscal 2025-end.

EnerSys generated net cash of $219 million from operating activities in the first six months of fiscal 2026 compared with $44 million in the year-ago period. Capital expenditure totaled $53.9 million compared with $66.4 million in the previous fiscal year.

In the first six months of fiscal 2026, EnerSys rewarded its shareholders with a dividend payout of approximately $18.9 million, up 1.7% year over year.

ENS’ GuidanceFor third-quarter fiscal 2026 (ending September 2025), EnerSys expects adjusted earnings to be in the range of $2.71–$2.81 per share, indicating growth of 36% at the mid-point. Net sales are expected to be in the band of $920–$960 million.

ENS’ Zacks RankPerformance of Other CompaniesDover Corporation (DOV - Free Report) reported earnings of $2.62 per share in third-quarter 2025, beating the Zacks Consensus Estimate of $2.50. This compares with earnings of $2.27 per share a year ago.

Dover posted revenues of $2.08 billion in the quarter, missing the Zacks Consensus Estimate by 0.6%. This compares with year-ago revenues of $1.98 billion.

Ardagh Metal Packaging S.A. (AMBP - Free Report) came out with earnings of eight cents per share in the third quarter of 2025, beating the Zacks Consensus Estimate of seven cents. This compares with earnings of eight cents per share a year ago.

Ardagh Metal posted revenues of $1.43 billion in the quarter, beating the Zacks Consensus Estimate by 2.7%. This compares with year-ago revenues of $1.31 billion.

Packaging Corporation of America (PKG - Free Report) reported earnings of $2.73 per share in the third quarter, missing the Zacks Consensus Estimate of $2.83. This compares with earnings of $2.65 per share a year ago.

Packaging Corp. posted revenues of $2.31 billion in the quarter, surpassing the Zacks Consensus Estimate by 2.2%. This compares with year-ago revenues of $2.18 billion.
2025-11-07 17:27 4mo ago
2025-11-07 12:11 4mo ago
OLED's Q3 Earnings Miss Estimates, Revenues Decline Y/Y stocknewsapi
OLED
Key Takeaways Universal Display's Q3 net income fell to $44M, or $0.92 per share, missing estimates.Revenue declined 14% year over year to $139.6M, hurt by weaker royalty and license fees.Gross margin slipped to 75% from 78%, while management focuses on operational improvements.
Universal Display Corporation (OLED - Free Report) reported soft third-quarter 2025 results, with both adjusted earnings and revenues falling short of the respective Zacks Consensus Estimate. The company reported a top-line decline year over year, owing to lower material sales, royalty and license fees.

However, growing OLED proliferation in multiple end markets, such as consumer electronics and automotive, is a major growth driver. A strong balance sheet and robust supply chain are positives. Management is undertaking several measures to improve operational and strategic infrastructure to bolster its leadership position in the industry.

Net Income of OLEDNet income in the third quarter was $44 million or 92 cents per share compared with $66.9 million or $1.40 in the year-ago quarter. Top-line decline hindered the net income growth. The bottom line missed the Zacks Consensus Estimate by 27 cents.

Revenues of OLEDThe company generated $139.6 million in revenues, down from $161.6 million in the year-ago quarter. Lower royalty and license fees impeded the top line. The top line missed the consensus estimate of $163 million.

Material sales contributed $82.6 million to revenues compared with $83.4 million in the prior-year quarter. The net sales beat our estimate of $82 million. Revenues from green emitter sales marginally rose to $65 million from $63 million in the year-ago quarter, whereas those from red emitter sales were $17 million compared to $20 million in the year-ago quarter.

Revenues from royalties and license fees were $53.3 million, down from $74.6 million in the year-ago quarter. The net sales missed our estimate of $73.9 million.

Revenues from Contract research services were $3.66 million compared with $3.6 million in the prior-year quarter. The segment’s revenues missed our estimate of $6 million.

Other Details of OLEDQuarterly gross profit was $104.1 million compared to $125.8 million in the prior-year quarter. The gross margin was 75%, down from 78% a year ago. Operating income was $43.1 million and the margin was 40% compared with the year-ago quarter’s $67 million and 41%, respectively.

OLED’s Cash Flow & LiquidityIn the first nine months of fiscal 2025, Universal Display generated $179.7 million in cash from operating activities compared with $219.1 million in the year-ago period. As of Sept. 30, 2025, the company had $121.6 million in cash and cash equivalents and $55.7 million in retirement plan benefit liability.

OLED’s GuidanceFor 2025, the company currently expects revenues in the range of $650-700 million, up from $640-700 million previously forecasted. The gross margin is predicted at 76-77%.

Despite some uncertainties in the near term, associated with geopolitical volatilities and imposition of tariffs, management remains optimistic about the company’s long-term growth potential. Growing OLED usage in IT applications encompassing tablets, laptops, monitors, automotive and various other consumer electronics applications, such as smartphones and TVs, will likely drive growth in the upcoming quarters.

Zacks Rank & Other Stocks to ConsiderUniversal Display currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Upcoming ReleasesKeysight Technologies, Inc. (KEYS - Free Report) is scheduled to release fourth-quarter fiscal 2025 earnings on Nov. 24. The Zacks Consensus Estimate for earnings is pegged at $1.83 per share, suggesting a growth of 10.9% from the year-ago reported figure.

Keysight has a long-term earnings growth expectation of 11.5%. Keysight delivered an average earnings surprise of 4.7% in the last four reported quarters.

Workday, Inc. (WDAY - Free Report) is set to release third-quarter 2025 earnings on Nov. 25. The Zacks Consensus Estimate for earnings is pegged at $2.12 per share, implying growth of 12.17% from the year-ago reported figure.

Workday has a long-term earnings growth expectation of 21.25%. The company delivered an average earnings surprise of 9.35% in the last four reported quarters.

AST SpaceMobile, Inc. (ASTS - Free Report) is set to release third-quarter 2025 earnings on Nov. 10. The Zacks Consensus Estimate for earnings is pegged at a loss of 18 cents per share, implying a growth of 25% from the year-ago reported figure.

AST SpaceMobile has a long-term earnings growth expectation of 28.3%. The Zacks Consensus Estimate for revenues is pegged at $20.74 million, implying a growth of 1,785.4% from the year-ago reported figure.
2025-11-07 17:27 4mo ago
2025-11-07 12:11 4mo ago
OXY Stock Set to Post Q3 Earnings: What to Expect This Season? stocknewsapi
OXY
Key Takeaways OXY's Q3 revenues and EPS are expected at $6.72B and 48 cents, down 6.04% and 52% respectively, YoY.Q3 Production volumes are expected in the range of 1,415-1,455 Mboe/d. Higher Permian volumes and cost cuts may aid margins despite weaker pricing.
Occidental Petroleum Corporation (OXY - Free Report) is expected to report a year-over-year decline in both top and bottom lines when it reports third-quarter 2025 results on Nov. 10, after market close.

The company’s earnings beat estimates in the last four reported quarters, with an average surprise of 25.72%.

Let us focus how things are shaping up for the upcoming earnings release.

Factors Likely to Have Shaped OXY’s Q3 EarningsOXY’s third-quarter production volumes are expected to have improved compared with the previous quarter, primarily due to improvements in Permian activity levels and higher production volumes in all of its main operating areas.

The third-quarter earnings might have benefited from strong domestic demand for PVC, but oversupply in the market remains a concern. A muted contribution is expected from OXY’s Midstream and Marketing in the third quarter, assuming the Waha to Gulf Coast natural gas spread continues to narrow from previous levels.

Occidental has been generating cash flow and utilizing the same to reduce debts, which is likely to have a positive impact on earnings. The company retired debts worth $7.5 billion, which lowered annual interest expenses by $410 million; undoubtedly, it will have a positive impact on earnings per share.

Occidental’s cost management initiatives have been yielding positive results and are likely to have improved margins with a positive impact on earnings.

Q3 ExpectationThe Zacks Consensus Estimate for OXY’s third-quarter revenues is pegged at $6.72 billion, indicating a decline of 6.04% from the year-ago reported figure.

The consensus mark for earnings is pegged at 48 cents per share. The Zacks Consensus Estimate for OXY’s third-quarter earnings indicates a decline of 52% from the year-ago reported figure.

For the third quarter of 2025, Occidental expects production of 1,415-1,455 thousand barrels of oil equivalent per day (Mboe/d). Output from the Permian Resources segment is anticipated at 779-799 Mboe/d.

What the Zacks Model UnveilsOur model does not predict a likely earnings beat for OXY this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. That is not the case here, as you can see below.

Earnings Surprise by Others This SeasonHere are some stocks in the same sector that have reported positive earnings surprise this season.

Devon Energy Corp. (DVN - Free Report) reported third-quarter 2025 earnings per share (EPS) of $1.04, beating the Zacks Consensus Estimate of 93 cents by 11.8%.

Long-term (three to five years) earnings growth of the company is pegged at 3.28%. The Zacks Consensus Estimate of DVN’s 2025 earnings per share indicates a year-over-year decline of 18.46%.

Murphy Oil Corporation (MUR - Free Report) delivered third-quarter 2025 adjusted net earnings of 41 cents per share, which beat the Zacks Consensus Estimate of 16 cents by 156.3%.

The Zacks Consensus Estimate of MUR’s 2025 earnings per share indicates a year-over-year decline of 57.61%.

Chevron Corporation (CVX - Free Report) reported adjusted third-quarter earnings per share of $1.85, beating the Zacks Consensus Estimate of $1.66.

Long-term (three to five years) earnings growth of the company is pegged at 4.91%. The Zacks Consensus Estimate of CVX’s 2025 earnings per share indicates a year-over-year decline of 27.46%.
2025-11-07 17:27 4mo ago
2025-11-07 12:15 4mo ago
Boeing South Carolina Breaks Ground on 787 Site Expansion stocknewsapi
BA
Expanded footprint to support future 787 production increases as global demand grows.
Project to support 1,000 new jobs and more than $1 billion in investments.
, /PRNewswire/ -- Boeing [NYSE:BA] today marked the groundbreaking of its Boeing South Carolina (BSC) site expansion. Home of the 787 Dreamliner program, BSC is set to increase production to a rate of 10 airplanes per month in 2026. The new expansion will allow the site to support higher 787 production rates given strong market demand.

A rendering of Boeing’s Second 787 Final Assembly Building when complete (Credit: Boeing)

In late 2024, Boeing announced plans to expand and upgrade its site near Charleston International Airport and a second campus. The company is investing more than $1 billion in this infrastructure program and plans to create more than 1,000 new jobs over the next five years. The expansion will include:

A new final assembly building similar in size to the current final assembly building, which is roughly 1.2 million square feet, and will include airplane production positions, production support and office space.
A parts preparation area facility, a vertical fin paint facility, Flight Line stalls and more at the Airport Campus.
Additions to the Interiors Responsibility Center, where many of the 787's interior components are made.

The construction effort will employ more than 2,500 people with over 6.2 million construction hours from the joint venture of HITT Contracting and BE&K Building Group.

Ninety customers from around the world have placed more than 2,250 orders for the 787 Dreamliner family, making it the best-selling widebody passenger airplane of all time.  

After more than 1,200 deliveries, the 787 backlog stands at nearly 1,000 airplanes, including more than 300 orders added just this year. In all, the commercial aviation industry is expected to need more than 7,800 new widebody airplanes over the next two decades, according to Boeing's Commercial Market Outlook.

"We continue to see strong demand for the 787 Dreamliner family and its market-leading efficiency and versatility. We are making this significant investment today to ensure Boeing is ready to meet our customer's needs in the years and decades ahead, said Stephanie Pope, president and CEO of Boeing Commercial Airplanes. "This site expansion is a testament to the incredible work of our Boeing teammates and deepens our commitment to them, to South Carolina, and to American manufacturing."

For more than a decade, BSC has been the home of the full 787 Dreamliner production cycle. Teammates fabricate, assemble and deliver the three Dreamliner models – 787-8, 787-9 and 787-10 – to customers around the world. The company established operations in South Carolina in 2009 and currently employs more than 8,200 people across its campuses in North Charleston and in Orangeburg.

"With visionary leadership, President Trump is restoring America's industrial base and breathing life back into our great manufacturing states, including the great state of South Carolina," said U.S. Treasury Secretary Scott Bessent. "We are proud to work alongside American businesses to build the world's greatest products, create high-paying jobs, and safeguard the economic and national security of our nation."

"Boeing's continued investment in South Carolina is a tremendous vote of confidence in our state's people and business climate," said South Carolina Governor Henry McMaster. "This $1 billion expansion and the creation of 1,000 new jobs will strengthen our position as a global leader in aerospace and advanced manufacturing. We are grateful for Boeing's partnership and commitment to the Lowcountry, which will bring new opportunities and economic prosperity across our state."

"Boeing's decision to dramatically increase production capability of the 787 in Charleston is the ultimate vote of confidence for the South Carolina workforce," said U.S. Senator Lindsey Graham. "I'm so pleased that Boeing is putting its money where its mouth is when it comes to South Carolina. The Boeing employees in our state have proven that they are worth the investment. This expanded production will create more jobs and ensure the viability of Boeing in South Carolina for decades to come."

"Today's groundbreaking represents a significant milestone not just for Boeing but for the state of South Carolina," said U.S. Senator Tim Scott. "This expansion will create more than a thousand quality jobs and reinforce our state's leadership in developing a strong workforce and pro-business environment. I look forward to the opportunities and prosperity this investment will bring to the Lowcountry and beyond."

"The expansion of the Boeing plant in North Charleston is welcome news," said U.S. Congressman Jim Clyburn. "Boeing has positioned South Carolina as a leader in the manufacturing and aerospace industry, and has created unprecedented opportunity for our workforce. This new expansion will create 1,000 new jobs. I'm thrilled for this next phase of growth, and look forward to our continuing partnership."

Imagery will be available on the Boeing Media Asset Portal following the event by 4:00 p.m. Eastern.

About Boeing:
A leading global aerospace company and top U.S. exporter, Boeing develops, manufactures and services commercial airplanes, defense products and space systems for customers in more than 150 countries. Our U.S. and global workforce and supplier base drive innovation, economic opportunity, sustainability and community impact. Boeing is committed to fostering a culture based on our core values of safety, quality and integrity.  

About BE&K | HITT Joint Venture:
HITT Contracting, a top national commercial construction firm with offices in 14 U.S. markets, including Charleston, and BE&K Building Group, a leading national design-build and construction management firm specializing in aviation and aerospace construction, are partnering to deliver the infrastructure upgrade. BE&K | HITT will serve as the construction manager for the project, with BRPH as the architect of record.

Contact
Boeing Media Relations
[email protected]

SOURCE Boeing
2025-11-07 17:27 4mo ago
2025-11-07 12:15 4mo ago
SUBMISSION OF REQUEST FOR THE REVISION OF THE VOLUNTARY SHARE EXCHANGE TENDER OFFER MADE BY EURONEXT N.V. (“OFFEROR” OR “EURONEXT”) FOR THE ORDINARY REGISTERED SHARES OF HELLENIC EXCHANGES-ATHENS STOCK EXCHANGE S.A. stocknewsapi
EUXTF
ANNOUNCEMENT SUBMISSION OF REQUEST FOR THE REVISION OF THE VOLUNTARY SHARE EXCHANGE TENDER OFFER MADE BY EURONEXT N.V. (“OFFEROR” OR “EURONEXT”) FOR THE ORDINARY REGISTERED SHARES OF HELLENIC EXCHANGES-ATHENS STOCK EXCHANGE S.A.
2025-11-07 17:27 4mo ago
2025-11-07 12:15 4mo ago
DXCM Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges DXCM Investors with Losses to Contact the Firm stocknewsapi
DXCM
, /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against DexCom, Inc. ("DexCom") (NASDAQ: DXCM) on behalf of those who purchased or otherwise acquired DexCom securities between July 26, 2024, and September 17, 2025, inclusive (the "Class Period"). The lead plaintiff deadline is December 26, 2025.

CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP:
If you suffered DexCom losses, you may CLICK HERE or copy and paste the following link into your browser: https://www.ktmc.com/new-cases/dexcom-inc-1?utm_source=PR_Newswire&mktm=PR

You can also contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or by email at[email protected]. 

DEFENDANTS' ALLEGED MISCONDUCT:
The complaint alleges that, throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) DexCom had made material design changes to its G6 and G7 continuous glucose monitoring systems that were unauthorized by the FDA; (2) the foregoing design changes rendered the G6 and G7 less reliable than their prior iterations, presenting a material health risk to users relying on those devices for accurate glucose readings; (3) DexCom's purported enhancements to the G7, as well as the device's reliability, accuracy, and functionality, were overstated; (4) DexCom downplayed the true scope and severity of the issues and health risks posed by adulterated G7 devices; (5) all the foregoing subjected DexCom to an increased risk of heightened regulatory scrutiny and enforcement action, as well as significant legal, reputational, and financial harm; and (6) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

THE LEAD PLAINTIFF PROCESS:
DexCom investors may, no later than December 26, 2025, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

Kessler Topaz Meltzer & Check, LLP encourages DexCom investors who have suffered significant losses to contact the firm directly to acquire more information.

CLICK HERE TO SIGN UP FOR THE CASE OR GO TO: https://www.ktmc.com/new-cases/dexcom-inc-1? utm_source=PR_Newswire&mktm=PR

ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP:
Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world. The firm has developed a global reputation for excellence and has recovered billions of dollars for victims of fraud and other corporate misconduct. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud, abuse, misconduct and negligence by businesses and fiduciaries. The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com.

CONTACT:
Kessler Topaz Meltzer & Check, LLP
Jonathan Naji, Esq.
(484) 270-1453
280 King of Prussia Road
Radnor, PA 19087
[email protected]

May be considered attorney advertising in certain jurisdictions. Past results do not guarantee future outcomes.

SOURCE Kessler Topaz Meltzer & Check, LLP
2025-11-07 17:27 4mo ago
2025-11-07 12:16 4mo ago
Capital One Stock Rises 21.6% YTD: Is There More Upside Ahead? stocknewsapi
COF
Key Takeaways COF stock has climbed 21.6% in 2025, outpacing peers and broader market benchmarks.The $35.3B Discover deal and strong NII growth boost COF's position in credit cards.Dividend hikes, $16B buyback and solid liquidity underscore COF's financial strength.
Capital One Financial (COF - Free Report) stock has risen 21.6% so far this year, outperforming its close peers — Ally Financial (ALLY - Free Report) and OneMain Holdings, Inc. (OMF - Free Report) . Moreover, it has outperformed the Zacks Finance Sector and the S&P 500 index, while underperforming the industry over the same time frame.

Capital One’s YTD Price Performance

Image Source: Zacks Investment Research

Capital One’s adjusted earnings increased 47.3% to $16 per share in the first nine months of 2025 on a year-over-year basis. Further, its revenues rose 30.9% to $37.9 billion, driven by higher net interest income (NII) and non-interest income alongside an increase in loans held for investments. On the other hand, non-interest expenses rose 37.4% during the same period.

Despite an impressive performance this year, tariff policies, government shutdown, stretched valuations and fears of an artificial intelligence (AI) bubble burst have led to a volatile and tough macroeconomic backdrop.

Let us assess whether COF stock is worth adding to one’s portfolio amid the ongoing concerns.

Factors That Support Capital One StockStrategic Buyouts: Capital One has been pursuing opportunistic acquisitions to drive its revenues. In May 2025, the company acquired Discover Financial in an all-stock transaction valued at $35.3 billion, reshaping the landscape of the credit card industry, creating a behemoth and unlocking substantial value for shareholders. In the third quarter of 2025, net interest margin (NIM) rose 74 basis points (bps) sequentially on the back of a full-quarter impact of the Discover buyout.

Additionally, it acquired Velocity Black in 2023 to enhance customer experience. Other notable acquisitions include ING Direct USA, HSBC's U.S. Credit Card Portfolio and TripleTree. These have been instrumental in transforming the company from a monoline credit card issuer into a diversified financial services firm with a significant presence in retail banking, commercial lending and digital banking platforms.

Rate Path & Revenue Growth: Though the Federal Reserve reduced interest rates by 50 basis points (bps) this year and 100 bps in 2024, the rates are still relatively high compared to the 2020 and 2021 levels of near-zero. This will likely continue to support COF’s net interest income (“NII”) and net interest margin (“NIM”).

 Capital One’s NII recorded a compound annual growth rate (CAGR) of 6% over the five years ended 2024. The momentum for NII continued during the first nine months of 2025. Likewise, NIM expanded to 7.69% in the first nine months of 2025 from 6.83% in the prior year quarter.

 Though the company’s revenues declined marginally in 2020, the metric witnessed a five-year (2019-2024) CAGR of 6.5%. In the same time frame, net loans held for investment recorded a CAGR of 4.3%. The uptrend continued for revenues and loans during the first nine months of 2025.

Quarterly Revenue Trend

Image Source: Zacks Investment Research

Rising demand for credit card loans and online banking businesses is expected to drive NII and NIM growth. The company plans to continue to offer Discover credit card products as Discover-branded cards, along with the other consumer cards currently offered by Capital One. This will solidify its presence in an intensely competitive environment.

 COF continues to show strong momentum in its Domestic Credit Card segment, which contributed 93.7% of Credit Card net revenues in the first nine months of 2025. Segment net revenues grew 33.5% year over year, while domestic credit card loans surged 70% during the same period.

Further, Capital One's "Digital First" banking model, characterized by its iconic customer experience and fee-free offerings, will be bolstered by Discover Financial's national direct savings bank. This synergy will increase the combined company's ability to compete with the nation's largest banks while accelerating national banking growth.

Sales Estimates

Image Source: Zacks Investment Research

Solid Balance Sheet: As of Sept. 30, 2025, Capital One had a total debt (securitized debt obligations plus other debt) of $51.5 billion. The total cash and cash equivalents balance was $55.3 billion. Additionally, the company holds investment-grade long-term senior debt ratings of Baa1, BBB and A- from Moody’s Investor Service, the Standard and Poor’s and Fitch Ratings, respectively. This renders the company favorable access to the debt market.

 As of Sept. 30, 2025, Capital One’s common equity tier 1 ratio and the total capital ratio of 14.4% and 17.4%, respectively, were well above the regulatory requirements. Further, the company has an average liquidity coverage ratio of 161%.

Average Liquidity Coverage Ratio

Image Source: Capital One Financial Corp.

Capital One’s focus on maintaining strong capital and balance sheet positions supports its capital distribution activities. Earlier this week, the company hiked its dividend by 33.3% to 80 cents per share. The bank has hiked dividends thrice during the last five years, with a dividend payout ratio of 13%.

Dividend Yield

Image Source: Zacks Investment Research

Similarly, Ally Financial and OneMain increased their dividends twice and six times over the past five years, respectively.

Further, in October 2025, its board of directors replaced the previous share repurchase program, authorizing up to $16 billion of shares. Given its earnings strength and solid liquidity position, the company’s enhanced capital distribution plans look sustainable.

Bullish Analyst Sentiments for Capital OneOver the past month, the Zacks Consensus Estimate for 2025 and 2026 earnings of $18.64 and $19.79 has been revised upward by 8.9% and 2.8%, respectively.

Estimate Revision Trend

Image Source: Zacks Investment Research

The projected figures imply year-over-year growth of 33.5% and 6.2% for 2025 and 2026, respectively.

How to Approach Capital One Stock NowCapital One is well-positioned to capitalize on the Discover acquisition and expand its presence in the growing credit card market. Its revenue diversification efforts, relatively higher interest rates and a solid balance sheet will continue to support its financials.

However, steadily rising expenses are a headwind. The company recorded a five-year CAGR of 6.8% (ended 2024) in non-interest expenses, mainly due to higher marketing costs and inflationary pressures. The uptrend persisted during the first nine months of 2025. Expense levels are expected to remain elevated, given the company’s investments in technology and infrastructure, as well as inorganic expansion efforts. The rise in the cost of modern technology talent and continued investments in growth opportunities will strain annual operating efficiency in the near term.

 Deteriorating asset quality is another concern. Capital One’s provisions and net charge-offs (NCOs) recorded a CAGR of 13.4% and 11.4% over the five years ended 2024. The trend persisted for both during the first nine months of 2025. Amid a challenging macroeconomic backdrop, provisions and NCOs are likely to remain elevated in the near term.

In terms of valuation, COF’s price-to-book ratio (P/B) of 1.22X is higher than the industry's 0.81X. Thus, the stock is trading at a premium.

P/B Ratio

Image Source: Zacks Investment Research

Meanwhile, its peers Ally Financial and OneMain have a P/B ratio of 0.93X and 2.14X, respectively. This indicates that Capital One is trading at a premium to Ally Financial and at a discount relative to OneMain.

Capital One has been allocating capital efficiently. This is demonstrated by the company’s return on equity (ROE) of 10.94% compared with the industry’s ROE of 10.22%.

ROE

Image Source: Zacks Investment Research

Additionally, rising credit card demand will continue to drive its revenues. This is reflected in the bullish analyst sentiments regarding the company’s long-term prospects. Thus, Capital One remains an attractive bet at the moment.

Currently, COF sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
2025-11-07 17:27 4mo ago
2025-11-07 12:16 4mo ago
Scotts Miracle-Gro's Q4 Earnings and Revenues Miss Estimates stocknewsapi
SMG
Key Takeaways SMG reports fiscal Q4 loss of $151.8M, narrower than last year.Net sales fall 6.6% to $387.4M, as U.S. Consumer gains offset Hawthorne's steep 38% decline.FY26 guidance calls for low single-digit U.S. growth and EPS between $4.15 and $4.35.
The Scotts Miracle-Gro Company (SMG - Free Report) reported a fourth-quarter fiscal 2025 (ended Sept. 30, 2025) loss of $151.8 million or $2.63 per share compared with a loss of $244 million or $4.29 per share in the year-ago quarter.

Barring one-time items, adjusted loss was $1.96 per share, narrower than $2.31 a year ago. The figure was wider than the Zacks Consensus Estimate of a loss of $1.88.

Net sales decreased around 6.6% year over year to $387.4 million and missed the consensus mark of $398.6 million.

SMG’s Segment DetailsIn the fiscal fourth quarter, net sales in the U.S. Consumer division were up 0.5% year over year to $311.2 million. It missed our estimate of $360 million. The segment delivered a loss of $65.5 million, up 21% year over year.

Net sales in the Hawthorne segment tumbled 38% year over year to $49.9 million in the reported quarter. The figure beat our estimate of $27 million. 

Net sales in the other segment increased 7% year over year to $26.3 million. The figure topped our estimate of $5.3 million. The segment reported a loss of $9.8 million, down 20% year over year.

SMG’s Balance SheetAt the end of the quarter, the company had cash and cash equivalents of $36.6 million, down from $71.6 million a year ago. Long-term debt was $2,049.2 million, down around 5.7% year over year.

SMG’s OutlookThe company provided its full-year fiscal 2026 outlook. Key projections include low single-digit growth in U.S. Consumer net sales. The adjusted gross margin is expected to be at least 32%, with adjusted EBITDA anticipated to grow in the mid-single digits. Adjusted earnings per share are projected to be between $4.15-$4.35, and free cash flow is estimated at approximately $275 million.

SMG’s Price PerformanceShares of Scotts Miracle-Gro have lost 19% in the past year compared the 5.4% decline of the industry.

Image Source: Zacks Investment Research

SMG’s Zacks Rank & Other Key PicksSMG currently carries a Zacks Rank #2 (Buy).

Some other top-ranked stocks worth a look in the basic materials space are AngloGold Ashanti plc (AU - Free Report) , U.S. Gold Corp. (USAU - Free Report) and Integra Resources Corp. (ITRG - Free Report) .

AngloGold is scheduled to report third-quarter results on Nov. 11. The Zacks Consensus Estimate for AU’s third-quarter earnings and revenues is pegged at $1.34 per share and $2.35 billion, respectively. AU currently flaunts a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

U.S. Goldis expected to report fiscal second-quarter results on Dec. 15. USAU carries a Zacks Rank #2 at present. The Zacks Consensus Estimate for USAU’s second-quarter earnings is pegged at a loss of 13 cents, indicating a 35% year-over-year growth.

Integra Resources is scheduled to report third-quarter results on Nov. 12. ITRG’s earnings estimate for the third quarter is pegged at 13 cents per share. Integra Resources carries a Zacks Rank #2 at present.
2025-11-07 17:27 4mo ago
2025-11-07 12:16 4mo ago
IONQ Stock Jumps Despite Wider Q3 Losses: Hold or Book Profit Now? stocknewsapi
IONQ
IONQ rallies 7.6% as revenues surge 222% and milestones pile up, even amid steep Q3 losses and a lofty valuation.
2025-11-07 17:27 4mo ago
2025-11-07 12:16 4mo ago
Middleby's Q3 Earnings and Sales Beat Estimates, Increase Y/Y stocknewsapi
MIDD
Key Takeaways Middleby's Q3 EPS of $2.37 topped estimates and rose 3% despite lower organic sales.Net sales grew 4.2% to $982M, driven by acquisitions and favorable currency impacts.MIDD expects Q4 sales of up to $1.02B and 2025 EPS as high as $9.14, signaling steady growth.
The Middleby Corporation (MIDD - Free Report) reported third-quarter 2025 adjusted earnings of $2.37 per share, which beat the Zacks Consensus Estimate of $2.03. The bottom line increased 3% year over year due to lower sales.

Net sales of $982 million beat the consensus estimate of $957 million. The top line increased 4.2% year over year. Organic sales decreased 0.1%. Acquired assets increased sales by 3.3%, while movements in foreign currencies had a positive impact of 1%.

MIDD’s Segmental ResultsSales from the Commercial Foodservice Equipment Group segment (representing 61.7% of net sales) were $606 million, up 2.4% year over year. Our estimate was $589.9 million. Organic sales increased 1.6%. Buyouts had a positive impact of 0.3% on sales, while foreign-currency translation had a positive impact of 0.5%.

Sales from the Residential Kitchen Equipment Group segment (17.8) totaled $174.8 million, up 0.9% year over year. Our estimate was $172.7 million. Organic sales decreased 0.6%. Foreign-currency translation had a favorable impact of 1.5%.

Sales from the Food Processing Equipment Group segment (20.5%) totaled $201.3 million, up 13.2% year over year. We expected the metric to be $195.0 million. Organic sales decreased 5.6% year over year. Acquisitions boosted sales by 3.3%, while foreign currency movements had a favorable impact of 1%.

Middleby’s Margin ProfileMiddleby’s cost of sales increased 5.7% year over year to $620.8 million. Gross profit inched up 1.7% to $361.3 million. The gross margin was 36.8%, down 90 basis points (bps) from the year-ago quarter.

Selling, general and administrative expenses increased 13.6% year over year to $203.6 million. Operating income decreased 10.7% year over year to $154.9 million. Operating margin decreased 260 bps to 18.4%.

Adjusted EBITDA decreased 7.8% year over year to $196.4 million. Adjusted EBITDA margin decreased 260 bps to 20.0%.

MIDD’s Balance Sheet and Cash FlowExiting the third quarter, Middleby had cash and cash equivalents of $175.1 million compared with $689.5 million at the end of December 2024. Long-term debt was $2.03 billion at the end of the third quarter compared with $2.35 billion at 2024-end.

In the first nine months of 2025, Middleby generated net cash of $439.5 million from operating activities compared with $447.1 million in the year-ago period.

In the first nine months, its capital expenditure totaled $74.9 million compared with $36.2 million in the year-ago period. Free cash flow was $364.6 million compared with $410.9 million in the year-ago period.

Middleby’s Q4 OutlookFor the fourth quarter, the company expects total sales to be in the range of $990 million-$1.02 billion. It expects sales from the Commercial Foodservice segment to be in the band of $570-$580 million, while sales from the Residential Kitchen segment are anticipated to be $180-$190 million. Sales from the Food Processing are projected to be about $240-$250 million.

While adjusted EBITDA is projected to be $200-210 million, adjusted earnings are anticipated to be in the band of $2.19-2.34 per share.

2025 OutlookFor 2025, Middleby expects total sales to be in the range of $3.85-3.89 billion. While adjusted EBITDA is forecasted to be $779-789 million, adjusted earnings are likely to be $8.99-9.14 per share.

MIDD’s Zacks RankPerformance of Other CompaniesDover Corporation (DOV - Free Report) reported earnings of $2.62 per share in third-quarter 2025, beating the Zacks Consensus Estimate of $2.50. This compares with earnings of $2.27 per share a year ago.

Dover posted revenues of $2.08 billion in the quarter, missing the Zacks Consensus Estimate by 0.6%. This compares with year-ago revenues of $1.98 billion.

Ardagh Metal Packaging S.A. (AMBP - Free Report) came out with earnings of eight cents per share in the third quarter of 2025, beating the Zacks Consensus Estimate of seven cents. This compares with earnings of eight cents per share a year ago.

Ardagh Metal posted revenues of $1.43 billion in the quarter, beating the Zacks Consensus Estimate by 2.7%. This compares with year-ago revenues of $1.31 billion.

Packaging Corporation of America (PKG - Free Report) reported earnings of $2.73 per share in the third quarter, missing the Zacks Consensus Estimate of $2.83. This compares with earnings of $2.65 per share a year ago.

Packaging Corp. posted revenues of $2.31 billion in the quarter, surpassing the Zacks Consensus Estimate by 2.2%. This compares with year-ago revenues of $2.18 billion.
2025-11-07 17:27 4mo ago
2025-11-07 12:16 4mo ago
SoundHound AI, Inc. (SOUN) Q3 2025 Earnings Call Transcript stocknewsapi
SOUN
Q3: 2025-11-06 Earnings SummaryEPS of -$0.03 beats by $0.00

 |

Revenue of

$42.05M

(67.57% Y/Y)

beats by $1.57M

SoundHound AI, Inc. (SOUN) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST

Company Participants

Scott Smith - Head of Investor Relations
Keyvan Mohajer - Co-Founder, CEO, President & Director
Nitesh Sharan - Chief Financial Officer

Conference Call Participants

Gil Luria - D.A. Davidson & Co., Research Division
Caden Dahl - Piper Sandler & Co., Research Division
Scott Buck - H.C. Wainwright & Co, LLC, Research Division
Leo Carpio - Joseph Gunnar & Co., LLC, Research Division

Presentation

Operator

Good day, and thank you for standing by. Welcome to SoundHound's Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker today, Scott Smith, Head of Investor Relations. Please go ahead.

Scott Smith
Head of Investor Relations

Good afternoon, and thank you for joining our third quarter 2025 conference call.

With me today is our CEO, Keyvan Mohajer; and our CFO, Nitesh Sharan. We will begin with some short remarks before moving to Q&A.

We'd also like to remind everyone that we will be making forward-looking statements on this call. Actual results could differ materially from those suggested by our forward-looking statements. Please refer to our filings with the SEC for a detailed discussion of the risks and uncertainties that could affect our business and for discussion statements that qualify as forward-looking statements.

In addition, we may discuss certain non-GAAP measures. Please refer to today's press release for more detailed financial results and further details on the definitions, limitations and uses of those measures and reconciliations from GAAP to non-GAAP. Also note that the forward-looking statements on this call are based on information available to us as of today's date. We undertake no obligation to update any forward-looking statements, except as required by law.

Recommended For You
2025-11-07 17:27 4mo ago
2025-11-07 12:19 4mo ago
Amgen Stock: New All-Time Highs Ahead After Earnings Beat stocknewsapi
AMGN
Amgen Inc. NASDAQ: AMGN just delivered a strong beat-and-raise quarter. That's pushed the stock to within striking distance of its 52-week high.
2025-11-07 17:27 4mo ago
2025-11-07 12:20 4mo ago
Natural Grocers® Expands Private-Label Brand With Organic Cooking Oils stocknewsapi
NGVC
The company's five new varieties deliver on taste, texture, convenience and affordability

, /PRNewswire/ -- When temperatures cool and daylight wanes, it's a great opportunity to get reacquainted with your stovetop and oven. Natural Grocers®, the nation's largest family-operated natural and organic grocery retailer, is introducing five new items in its cooking oil line to make things tastier and easier. Bake, sauté, drizzle—you name it—Natural Grocers® Brand Organic Cooking Oils are ready for every culinary adventure!

Since 2016, Natural Grocers Brand Products has grown to over 900 high-quality items—now including five new organic cooking oils, available exclusively at Natural Grocers stores.

"When it comes to everyday cooking, simple ingredients make all the difference," said Raquel Isely, vice president of marketing at Natural Grocers. "Natural Grocers Brand Organic Cooking Oils, are always organic and Always AffordableSM—because great cooking starts with great oil."

ORGANIC COOKING SPRAYS
Natural Grocers Brand Organic Cooking Oil Sprays are certified organic, non-GMO, kosher and aerosol-free. The nonstick sprays are also purity-tested and made without chemicals or solvents.

The Organic Avocado Oil Spray is expeller-pressed and made for high-heat tasks, from frying eggs to prepping egg rolls for the air fryer.
The Organic Extra Virgin Olive Oil Spray adds flavor and convenience anywhere it's applied, whether coating a cake pan or finishing roasted vegetables.
ORGANIC AVOCADO OILS & OLIVE OIL BLENDS
These oils are certified organic, non-GMO and kosher. Each product is expeller-pressed, purity tested and made without chemicals or solvents.

Not every oil can take the heat, but Natural Grocers Brand Organic Avocado Oil can. With a 500-degree smoke point, and mild flavor, it's a wholesome fat that complements everything from brownies to broccoli.
Versatility and flavor meet in Natural Grocers Brand Organic Avocado & Olive Oil Blend. This 50/50 blend is sure to be a kitchen mainstay for dressings, marinades and baking.
NEW PRODUCTS & PRICING
Customers are invited to try these new cooking oil varieties at a special introductory prices (listed below) through Nov. 29, 2025.

Organic Avocado Oil Spray (5 oz) – $4.49 introductory price
Organic Avocado Oil (8.5 oz) - $6.29 introductory price
Organic Avocado Oil (16.9 oz) - $9.99 introductory price
Organic Expeller Avocado & Olive Oil Blend (16.9 oz) – $9.49 introductory price
Organic Extra Virgin Olive Oil Spray (5 oz) – $4.49 introductory price
Beginning Nov. 30, the company's Always AffordableSM price will be as follows:

Organic Avocado Oil Spray (5 oz) – $4.99
Organic Avocado Oil (8.5 oz) - $6.99
Organic Avocado Oil (16.9 oz) - $10.99
Organic Expeller Avocado & Olive Oil Blend (16.9 oz) – $10.49
Organic Extra Virgin Olive Oil Spray (5 oz) – $4.99
RECENT ADDITIONS AND COMING SOON
Since its launch in 2016, Natural Grocers Brand Products has grown to more than 900 high-quality items, available exclusively at Natural Grocers stores. Learn more about Natural Grocers' Standards here. Recent additions to the private-label line include four new varieties of Organic Tortillas and Organic Whole Milk Yogurt, with even more premium-quality, Always Affordable products on the way.

Click here for a media kit, courtesy of Natural Grocers.
Contact Katie Macarelli: [email protected] for any press-related questions or sample requests.
ABOUT NATURAL GROCERS BY VITAMIN COTTAGE
Founded in 1955, Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) is an expanding specialty retailer of natural and organic groceries, body care products, and dietary supplements. The grocery products sold by Natural Grocers must meet strict quality guidelines and may not contain artificial flavors, preservatives, or sweeteners (as defined by its standards), synthetic colors, or partially hydrogenated or hydrogenated oils. The Company sells only USDA-certified organic produce and exclusively pasture-raised, non-confinement dairy products, and free-range eggs. Natural Grocers' flexible smaller-store format allows it to offer affordable prices in a shopper-friendly, clean, and convenient retail environment. The Company also provides extensive free science-based Nutrition Education programs to help customers and Crew make informed health and nutrition choices. Natural Grocers is committed to its Five Founding Principles—including its "Commitment to Community" and "Commitment to Crew". In fiscal year 2024, the Company invested more than $15 million in incremental compensation and discretionary payments for Crew. Headquartered in the Union Square neighborhood of Lakewood, CO, Natural Grocers has 168 stores in 21 states. Visit www.naturalgrocers.com for more information and store locations. 

SOURCE Natural Grocers by Vitamin Cottage, Inc.
2025-11-07 17:27 4mo ago
2025-11-07 12:21 4mo ago
Allogene Posts Narrower-Than-Expected Loss in Q3, Nil Sales stocknewsapi
ALLO
Key Takeaways Allogene posted a smaller Q3 loss of 19 cents per share versus an expected 23-cent loss.R&D and G&A expenses dropped 30% and 16% year over year, respectively.Allogene expects its $277M cash position to fund operations into the second half of 2027.
Allogene Therapeutics (ALLO - Free Report) incurred a third-quarter 2025 loss of 19 cents per share, narrower than the Zacks Consensus Estimate of a loss of 23 cents. In the year-ago period, the company had incurred a loss of 32 cents per share.

As the company lacks a marketed product in its portfolio, it did not report any sales during the quarter.

Year to date, shares of Allogene have plunged 51% against the industry’s 11% growth.

Image Source: Zacks Investment Research

More on ALLO’s ResultsResearch & development (R&D) expenses totaled $31 million, down 30% from the year-ago quarter’s level.

General and administrative (G&A) expenses declined 16% year over year to around $14 million.

As of Sept. 30, 2025, Allogene had $277 million in cash and cash equivalents compared with $303 million as of June 30, 2025.

ALLO’s 2025 GuidanceThe company reiterated its 2025 guidance. It expects operating expenses for the full year to be around $230 million, including nearly $45 million in non-cash stock-based compensation.

Cash burn for 2025 is expected to be around $150 million. Allogene believes that its cash runway will fund operations into the second half of 2027.

Updates on ALLO’s PipelineAllogene’s main focus is on the pivotal phase II ALPHA3 study, which is evaluating lead drug cema-cel as a potential first-line treatment for newly diagnosed and treated large B-cell lymphoma (LBCL) patients who are likely to relapse and need further therapy. The lymphodepletion selection and futility analysis from the study, along with MRD conversion rates, are expected in the first half of 2026.

The company is exploring the potential of allogeneic CAR-T cell therapies in autoimmune diseases. It recently initiated the phase I RESOLUTION basket study evaluating ALLO-329 across various autoimmune diseases, including systemic lupus erythematosus, idiopathic inflammatory myopathies and systemic sclerosis. Allogene expects to have both biomarker and clinical proof-of-concept data from this study by the first half of 2026.

Allogene is also developing a third candidate, ALLO-316, which is being evaluated in the phase I TRAVERSE study in patients with heavily pretreated, advanced or metastatic renal cell carcinoma (RCC). The company is currently exploring partnership opportunities to advance the development of this drug.

ALLO’s Zacks RankAllogene currently has a Zacks Rank #4 (Sell).

Our Key Picks Among Biotech StocksSome better-ranked stocks from the sector are Alkermes (ALKS - Free Report) , CorMedix (CRMD - Free Report) and ANI Pharmaceuticals (ANIP - Free Report) . While ALKS and CRMD sport a Zacks Rank #1 (Strong Buy) each at present, ANIP carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

EPS estimates for Alkermes’ 2025 have increased from $1.78 to $1.96, while those for 2026 have risen from $1.69 to $1.77 in the past 60 days. ALKS stock has gained 10% year to date.

Alkermes’ earnings beat estimates in three of the trailing four quarters and missed the mark on one occasion, delivering an average negative surprise of 4.58%.

In the past 60 days, estimates for CorMedix’s earnings per share (EPS) have increased from $1.24 to $1.85 for 2025. During the same time, EPS estimates for 2026 have increased from $2.09 to $2.49. Year to date, shares of CRMD have rallied 33%.

CorMedix’s earnings beat estimates in each of the trailing four quarters, the average surprise being 34.85%.

In the past 60 days, estimates for ANI Pharmaceuticals’ EPS have increased from $7.25 to $7.29 for 2025. During the same time, EPS estimates for 2026 have increased from $7.74 to $7.81. Year to date, shares of ANIP have surged 68%.

ANI Pharmaceuticals' earnings beat estimates in each of the trailing four quarters, the average surprise being 22.66%.
2025-11-07 17:27 4mo ago
2025-11-07 12:21 4mo ago
Is SoFi Technologies Stock a Buy After Another Record Quarter? stocknewsapi
SOFI
Key Takeaways SoFi reported record Q3 adjusted net revenues of $950M, up 38% year over year, beating estimates.Membership grew to 12.6M, with fee-based revenues reaching a record $409M, up 57% from last year.Management raised 2025 guidance across all metrics, citing strong momentum and innovation-led growth.
Investors had been eagerly awaiting SoFi Technologies’ (SOFI - Free Report) third-quarter results to gauge whether its strong business momentum could translate into further stock gains. However, the reaction surprised many; shares have fallen roughly 14% since the earnings release, even though both earnings and revenues handily beat estimates. This pullback appears more like a short-term sentiment correction rather than a reflection of fundamentals, as the company’s performance and outlook continue to strengthen.

SOFI delivered a stellar third quarter, underscoring its transformation from a digital lender to a diversified financial services platform. The company reported record adjusted net revenue of $950 million, up 38% year over year, beating the Zacks Consensus Estimate by 6.6%,marking its eighth consecutive profitable quarter. Net income reached $139 million, translating to earnings per share of 11 cents, beating the consensus estimate by 22%.

                                                                  Image Source: SoFi Technologies

SoFi’s membership base continues to expand rapidly, with 905,000 new members added in the quarter, bringing the total to 12.6 million.

                                                           Image Source: SoFi Technologies

Product adoption also surged; the firm reported 1.4 million new products, with 40% of them opened by existing members, demonstrating increasing cross-sell strength. This momentum reflects the success of SoFi’s integrated financial ecosystem, where members use multiple services across lending, investing and banking.

                                                       Image Source: SoFi Technologies

The company’s Financial Services and Technology Platform segments, which include SoFi Money, SoFi Invest, Galileo and Technisys, generated a combined $534 million in revenues, up 57% year over year. These businesses now contribute 56% of total revenues, showcasing progress toward a more capital-light, fee-driven model. Fee-based revenues hit a record $409 million in the quarter and are now annualizing at over $1.6 billion, a crucial milestone for long-term stability and profitability.

Product Innovation and Strategic ExpansionManagement’s focus on innovation continues to drive SoFi’s competitive advantage. The launch of SoFi Pay, enabling fast and low-cost international payments through blockchain, represents a strategic step into global financial connectivity. Plans for a SoFi USD stablecoin in 2026 further underscore its intent to capitalize on blockchain technology’s potential in mainstream finance.

The relaunch of crypto trading features, including buy, sell and hold options, within the SoFi app aligns with growing investor interest in digital assets. Meanwhile, the forthcoming AI-driven SoFi Coach, an expansion of its existing Cash Coach, promises to provide personalized, AI-powered financial guidance across users’ accounts.

Adding to its lineup, SoFi unveiled the SoFi Smart Card, combining 5% cash back on food purchases, credit-building features, and access to competitive deposit and borrowing rates. These moves not only strengthen SoFi’s ecosystem but also deepen customer engagement and brand loyalty.

Marketing partnerships are amplifying this momentum. A new collaboration with NFL MVP Josh Allen to promote SoFi Plus, the company’s premium product offering, highlights its growing brand strength. SoFi’s unaided brand awareness has now reached an all-time high of 9.1%, confirming its rising profile among U.S. consumers.

Financial Strength and Upbeat 2025 OutlookManagement reaffirmed SoFi’s operational discipline and growth trajectory. Adjusted EBITDA came in at a record $277 million with a 29% margin, while nonlending revenues surged 57% year over year. The lending segment also performed robustly, with $481 million in revenues, up 23% from last year. Total loan originations reached a record $9.9 billion, up 57% year over year, driven by strong demand for personal and home loans.

SoFi also strengthened its balance sheet, raising $1.7 billion in new capital and increasing total deposits by $3.4 billion to $32.9 billion. This growing deposit base enhances funding stability and supports lending expansion without excessive reliance on external financing.

Encouraged by the strong third performance, management raised its 2025 guidance across all metrics. The company now expects to add about 3.5 million members for the full year, indicating 34% growth, up from the earlier forecast of 30%. Adjusted net revenues are now projected at $3.54 billion, up 36% year over year and above the prior guide of $3.375 billion. Adjusted EBITDA guidance rose to $1.035 billion, while adjusted net income and EPS are now expected at $455 million and 37 cents, respectively, both meaningfully above previous estimates. Tangible book value growth is forecast at approximately $2.5 billion, far exceeding prior guidance of $640 million.

These raised targets indicate growing confidence in the company’s long-term profitability and its ability to scale its fee-based businesses efficiently.

SoFi is a Buy After Q3SoFi Technologies’ third quarter reaffirmed its status as one of the most dynamic digital finance companies in the United States. The combination of record revenue, accelerating membership growth, expansion into AI and blockchain, and rising nonlending income highlights a maturing business model built for sustainable growth.

With a Zacks Rank #2 (Buy), SoFi stands well-positioned for continued momentum into 2025 and beyond. The company’s emphasis on innovation, brand building, and diversification across capital-light revenue streams sets it apart in the evolving fintech landscape. For investors seeking exposure to a fast-growing, technology-forward financial platform, SoFi stock appears attractive for accumulation following its strong third-quarter earnings performance. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Other Stocks to Watch in Fintech

Block (XYZ - Free Report) , Robinhood (HOOD - Free Report) and PayPal (PYPL - Free Report) are three fintech names to keep on the radar. Block is deepening its ecosystem via Cash App and Square, aiming to unify consumer and merchant services. Robinhood is expanding beyond trading into full-scale financial services, with HOOD users growing steadily. Meanwhile, PayPal is leaning into branded checkout and expanding Venmo’s capabilities. Block, Robinhood and PayPal each face competitive pressure but continue to innovate across digital payment rails and user engagement models.
2025-11-07 17:27 4mo ago
2025-11-07 12:21 4mo ago
Citi CEO: 'The U.S. economy continues to defy the tariff doomsdayers' stocknewsapi
C
Jane Fraser, Citi CEO, said that the data contrasts consumer sentiment, and that the U.S. economy has been resilient despite what was forecasted by "tariff doomsdayers."
2025-11-07 17:27 4mo ago
2025-11-07 12:21 4mo ago
Peloton shares ride higher on Q1 earnings beat stocknewsapi
PTON
Peloton Interactive Inc (NASDAQ:PTON) shares jumped nearly 5% on Friday afternoon after the company reported stronger-than-expected fiscal first quarter 2026 earnings and issued an upbeat outlook for the coming quarters.

For the September quarter, Peloton posted revenue of $550.8 million, beating Wall Street estimates of $539.6 million.

Adjusted earnings per share (EPS) came in at $0.03, surpassing analyst expectations of breakeven ($0.00).

Net income rose to $14 million, up $15 million year-over-year, and adjusted EBITDA reached $118 million, a 2% increase from the prior year.

Free cash flow climbed to $67 million, up $57 million from the same period in 2024.

Ending paid connected fitness subscriptions totaled 2.732 million, slightly above the company’s guidance but down 6% year-over-year.

Looking ahead, Peloton issued a better-than-expected outlook for fiscal Q2, projecting revenue between $665 million and $685 million, a modest 0.2% increase year-over-year at the midpoint.

Gross margin is expected to rise to 49%, up 180 basis points from last year, and adjusted EBITDA is forecasted at $55 million to $75 million, up 11% at the midpoint.

Paid connected fitness subscriptions are projected to range from 2.64 million to 2.67 million, reflecting an 8% year-over-year decline at the midpoint.

For the full fiscal year 2026, Peloton expects total revenue of $2.4 billion to $2.5 billion, roughly in line with analyst estimates, while EPS is projected to turn positive at $0.17, improving from a prior negative estimate of $0.29 per share.

Adjusted EBITDA is forecasted at $425 million to $475 million, with free cash flow expected to reach at least $250 million.
2025-11-07 17:27 4mo ago
2025-11-07 12:25 4mo ago
Ten-Year Tally: Automatic Data Processing Stock Delivers $28 Bil Gain stocknewsapi
ADP
CHONGQING, CHINA - JULY 28: In this photo illustration, a person holds a smartphone displaying the logo of Automatic Data Processing Inc. (NASDAQ: ADP), a leading provider of human resources management software and services, with a bold red ADP logo visible in the background, on July 28, 2025 in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

Getty Images

Over the past ten years, Automatic Data Processing (ADP) stock has provided $28 Bil in returns to its shareholders in the form of cash through dividends and buybacks. Let us examine some figures and see how this payout capability compares to the largest capital-return entities in the market.

Interestingly, ADP stock ranks as the 100th highest in terms of returns to shareholders throughout history.

ADP

Trefis

Why should you care? Because dividends and share buybacks provide direct, tangible returns of capital to investors. They also demonstrate management’s confidence in the company's financial well-being and its capacity to generate sustainable cash flows. Moreover, there are additional stocks that exhibit similar traits. Here’s a ranking of the top 10 companies based on the total capital returned to shareholders via dividends and stock repurchases.

Portfolio strategy trumps stock-picking consistently. Imagine the potential long-term performance for your portfolio if you merged 10% commodities, 10% gold, and 2% crypto with equities.

MORE FOR YOU

Top 10 Stocks By Total Shareholder Return

ADP

Trefis

For the complete ranking, visit Buybacks & Dividends Ranking

What do you notice here? The overall capital returned to shareholders as a % of the current market cap seems inversely related to growth prospects for reinvestments. Stocks such as Meta (META) and Microsoft (MSFT) are growing significantly faster and in a more consistent manner compared to their counterparts, yet they have returned a much smaller percentage of their market cap to shareholders.

This is the flip side of high capital returns. While they are appealing, it raises an important question: Am I sacrificing growth and sound fundamentals? Keeping this in mind, let’s review some statistics for ADP. (see Buy or Sell Automatic Data Processing Stock for additional information)

Automatic Data Processing Fundamentals

Revenue Growth: 7.1% LTM and 7.4% average over the last 3 years.Cash Generation: Nearly 20.1% free cash flow margin and 26.2% operating margin LTM.Recent Revenue Shocks: The minimum annual revenue growth for ADP over the last 3 years was 6.6%.Valuation: Automatic Data Processing stock has a P/E ratio of 24.7ADP

Trefis

*LTM: Last Twelve Months

This provides a solid summary, but analyzing a stock from an investment viewpoint encompasses much more. That is precisely what Trefis High Quality Portfolio accomplishes. It aims to mitigate stock-specific risks while offering upside potential.

ADP Historical Risk

ADP is not exempt from significant declines. It experienced a drop of approximately 36% during the Dot-Com bubble and a similar decline during the Global Financial Crisis. The correction in 2018 resulted in a fall of nearly 19%, and the Covid market downturn impact was severe, with almost a 39% drop. The inflation shock was challenging as well, causing a 22% decrease. Strong fundamentals are essential, yet these figures indicate that even stable stocks can be adversely affected when the market shifts.

However, risks are not confined to substantial market declines. Stocks can also decline during favorable market conditions, especially during events like earnings announcements, business updates, and changes in outlook. Consult ADP Dip Buyer Analyses to review how the stock has bounced back from significant drops previously.

The Trefis High Quality (HQ) Portfolio, featuring a collection of 30 stocks, has a proven history of consistently outperforming its benchmark, which incorporates all three – S&P 500, S&P mid-cap, and Russell 2000 indices. Why is this the case? Collectively, HQ Portfolio stocks yielded superior returns with lower risk compared to the benchmark index, resulting in a smoother investment experience, as evidenced by HQ Portfolio performance metrics.
2025-11-07 17:27 4mo ago
2025-11-07 12:25 4mo ago
Grand Reset: Opendoor Technologies' Q3 Earnings Reaction stocknewsapi
OPEN
SummaryOpendoor Technologies is a high-risk, high-reward play aiming to disrupt the real estate market by streamlining home buying and selling.OPEN's fundamentals show strong recent cash flow and revenue, but current margins are unsustainable, and further restructuring is likely.OPEN trades at a compelling 1x revenue multiple, making it attractive despite volatility and the potential for significant price swings.We rate OPEN a Buy for risk-tolerant investors, but suggest careful position sizing due to the possibility of substantial losses.DISCLAIMER: This note is intended for U.S. recipients only and, in particular, is not directed at, nor intended to be relied upon by, any U.K. recipients. Nothing in this note is intended to be investment advice, nor should it be relied

Analyst’s Disclosure:I/we have a beneficial long position in the shares of OPEN either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Cestrian Capital Research, Inc staff personal accounts hold long position(s) in, inter alia, OPEN

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You
2025-11-07 17:27 4mo ago
2025-11-07 12:25 4mo ago
ESPR's Q3 Earnings Lag Estimates, Revenues Rise Y/Y, Stock Down stocknewsapi
ESPR
Key Takeaways ESPR posted a Q3 loss of $0.16 per share, which missed estimates and widened from last year's $0.15 loss.Q3 revenues surged 69% year over year to $87.3 million, driven by higher collaboration royalties and sales.ESPR expects 2025 operating expenses of $215-$235 million and aims for profitability in early 2026.
Esperion Therapeutics (ESPR - Free Report) incurred a loss of 16 cents per share in the third quarter of 2025, which was wider than the Zacks Consensus Estimate of a loss of 9 cents. The company had incurred a loss of 15 cents per share in the year-ago quarter.

Esperion generated total revenues of $87.3 million in the third quarter, reflecting a 69% year-over-year increase. Total revenues beat the Zacks Consensus Estimate of $83 million.

Shares of Esperion were down 15% on Nov. 6, probably due to the mixed results, indicating that the earnings miss might have hurt investors' sentiments.

The stock has increased 13.7% year to date compared to the industry’s rise of 3.7%.

Image Source: Zacks Investment Research

Esperion has two FDA-approved drugs in its commercial portfolio, Nexletol (bempedoic acid) and Nexlizet, which are approved for treating elevated LDL-C (bad cholesterol) and for cardiovascular risk reduction. Nexlizet is a combination of bempedoic acid and ezetimibe.

These two oral drugs are marketed as Nilemdo and Nustendi in ex-U.S. markets (excluding Japan, where the company has a collaboration with Otsuka Pharmaceuticals) in partnership with Daiichi Sankyo. The company records royalties on sales of its drugs in ex-U.S. markets.

ESPR's Q3 Results in DetailProduct revenues, solely from the United States, totaled $40.7 million in the third quarter, up 31% year over year. Product revenues missed the Zacks Consensus Estimate of $42.9 million.

Esperion recorded collaboration revenues, including combined royalty and partner revenues, of $46.7 million during the third quarter, up 128% year over year. This was driven by increases in royalty sales within partner territories and product sales to the company’s collaboration partners from its supply agreements.

Collaboration revenues beat the Zacks Consensus Estimate of $40.5 million but missed our model estimate of $47.7 million.

Research and development expenses increased 36% from the year-ago period’s levels to $14.1 million, reflecting higher costs in ongoing clinical studies.

Selling, general and administrative expenses were up 5% year over year to $41.8 million owing to higher legal costs associated with the abbreviated new drug application (“ANDA”) litigation and higher media costs.

As of Sept. 30, 2025, Esperion had cash, cash equivalents, restricted cash and investment securities of $92.4 million compared with $86.1 million as of June 30, 2025.

ESPR’s 2025 GuidanceEsperion continues to expect operating expenses in the range of $215-$235 million, including $15 million in non-cash expenses related to stock compensation during 2025.

The company expects to achieve sustainable profitability from the first quarter of 2026.

ESPR's Key Recent DevelopmentsLast month, Esperion nominated ESP-2001, a highly specific allosteric ATP citrate lyase (“ACLY”) inhibitor, as its new preclinical development candidate for the treatment of primary sclerosing cholangitis (“PSC”).

The company plans to initiate investigational new drug (“IND”)-enabling studies for ESP-2001 and submit an IND application to the FDA to start clinical studies in 2026.

Esperion recently reached a settlement agreement with Dr. Reddy’s (RDY - Free Report) related to patents for Nexletol and Nexlizet. The settlement agreement resolves the patent litigation brought by Esperion on RDY’s ANDA, seeking marketing approval for a generic version of each of Nexletol and Nexlizet in the United States before the applicable patents expire.

Per the settlement terms, Dr. Reddy’s has agreed not to launch a generic version of Nexletol or Nexlizet in the United States before April 19, 2040, except under certain limited conditions that are customarily included in such agreements.

ESPR’s Zacks Rank & Stocks to ConsiderEsperion currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the biotech sector are ANI Pharmaceuticals (ANIP - Free Report) and Arcutis Biotherapeutics (ARQT - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

In the past 60 days, estimates for ANI Pharmaceuticals’ earnings per share have increased from $7.25 to $7.29 for 2025. During the same time, earnings per share estimates for 2026 have increased from $7.74 to $7.81. Year to date, shares of ANIP have surged 63.2%.

ANI Pharmaceuticals' earnings beat estimates in each of the trailing four quarters, the average surprise being 22.66%.

In the past 60 days, estimates for Arcutis Biotherapeutics’ loss per share have narrowed from 44 cents to 24 cents for 2025. During the same time, earnings per share estimates for 2026 have increased from 9 cents to 41 cents. Year to date, shares of ARQT have rallied 80.1%.

Arcutis Biotherapeutics’ earnings beat estimates in each of the trailing four quarters, the average surprise being 64.80%.
2025-11-07 16:27 4mo ago
2025-11-07 10:42 4mo ago
XRP Price Weakens, Evernorth Records $78M Loss While Ripple Reaches $95B Valuation cryptonews
XRP
TL;DR:

Evernorth reports a $78M unrealized loss on XRP holdings.
XRP price drops below $2.20, down 40.1% from its peak.
Ripple achieves a $95B market capitalization despite token volatility.

XRP faced a sharp decline this week, falling below $2.20 amid market turbulence. Evernorth, the Ripple-backed digital asset treasury, now reports an unrealized loss of $78 million following its recent investments in XRP, a stark reminder of the volatility surrounding major cryptocurrencies. Investors and institutions closely monitor these movements as Ripple‘s broader ecosystem remains under scrutiny.

🚨 🚨 🚨 🚨 🚨 🚨 🚨 🚨 🚨 🚨 126,791,448 #XRP (280,200,797 USD) transferred from unknown wallet to unknown wallethttps://t.co/C3qJfwTRVW

— Whale Alert (@whale_alert) November 6, 2025

Institutional Investments and Market Repercussions
Ripple-backed Evernorth aims to acquire 473M XRP tokens for $1B but has encountered immediate market challenges, as CryptoQuant reports a $78 million loss in less than three weeks. The firm initially purchased an additional $214 million worth of XRP on Nov. 4, showing aggressive expansion despite heightened volatility. Such losses underscore the risks inherent in large-scale treasury strategies in crypto markets.

XRP’s intraday low hits $2.16, down 40.1% from its record high, emphasizing how quickly sentiment can shift. This drop coincided with Ripple reaching a $95 billion valuation, highlighting the contrast between corporate growth and individual asset volatility. Analysts note that XRP’s rapid decline, even as Ripple hits milestones, may impact investor confidence.

Evernorth has already purchased 388.7M XRP for around $947 million, yet market fluctuations have created significant unrealized losses. The treasury structure positions the firm as a major XRP holder, reflecting institutional confidence, but also exposing it to extreme price swings that could affect both liquidity and strategic plans.

Ripple’s market capitalization reaches $95B, showing that despite token-level losses, corporate valuation can continue to grow. This divergence reflects investor optimism in Ripple’s network and strategic developments, including partnerships and adoption across financial ecosystems.

Market observers caution that large treasury positions in volatile tokens like XRP require risk management and timing strategies, as high exposure to price swings can quickly erode gains, even in a strong network with growing adoption.
2025-11-07 16:27 4mo ago
2025-11-07 10:42 4mo ago
BNB Drops to Key Support Level Above $930 as Markets React to Liquidity Pressures cryptonews
BNB
BNB's ability to stay above its key $930 support may reflect confidence in the network's adoption, but a break above $975 could be needed to reopen the path toward recent highs. Nov 7, 2025, 3:42 p.m.

The native token of the BNB Chain, BNB, slipped slightly over the last 24-hour period, moving to $933 after briefly surging to $974, as broader crypto markets showed signs of stress tied to tightening financial conditions.

The token’s price action played out in a narrow $46 range. Volume rose sharply during the morning’s move higher, 71% above the 24-hour average, but cooled into the close according to CoinDesk Research's technical analysis data model.

STORY CONTINUES BELOW

The rejection near $975 marked a technical ceiling, while BNB found support once again near $930.

“BNB’s ability to hold support mirrors the broader strength we’re seeing on-chain,” Johnny B., the founder of BNBPad.ai, told CoinDesk in an emailed statement. “Despite the market headwinds, BNB Chain saw 82 million active addresses in October, a new all-time high, while DEX volumes neared $120 billion based on DeFiLlama.”

BNB’s muted performance came along a wider market drawdown. The broader market, as measured via the CoinDesk 20 (CD20) index, is down 0.9% in the last 24 hours while bitcoin is struggling to remain above $100,000.

A U.S. Treasury cash rebuild and falling bank reserves, down an estimated $500 billion since July, have drained capital from markets and made risk assets less attractive, according to a recent report from Citi.

That has seen stocks fall as well, with the tech-heavy Nasdaq 100 seeing a 4.7% decline this week, and the S&P 500 dropping by 2.7%.

In this environment, BNB’s ability to stay above its key $930 support level may reflect confidence in the network’s adoption and the performance of newer decentralized applications like Asper, even as the broader outlook dims.

A break above $975 could reopen the path toward recent highs, but further downside in major assets could test buyers’ resolve. BNB remains tied to technical setups for now, but broader market forces are starting to call the shots.

Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy.

More For You

Inside Zcash: Encrypted Money at Planetary Scale

Nov 3, 2025

A deep dive into Zcash's zero-knowledge architecture, shielded transaction growth, and its path to becoming encrypted Bitcoin at scale.

What to know:

In 2025, Zcash evolved from niche privacy tech into a functioning encrypted-money network:

Shielded adoption surged, with 20–25% of circulating ZEC now held in encrypted addresses and 30% of transactions involving the shielded pool.The Zashi wallet made shielded transfers the default, pushing privacy from optional to standard practice.Project Tachyon, led by Sean Bowe, aims to boost throughput to thousands of private transactions per second.Zcash surpassed Monero in market share, becoming the largest privacy-focused cryptocurrency by capitalization.View Full Report

More For You

Strategy Adds Europe to Capital Raising Efforts, Securing $715M in Newest Preferred Offering

1 hour ago

Dubbed "stream," STRE is the company's latest preferred series as Michael Saylor and team begin raising funds overseas for more bitcoin purchases.

What to know:

Strategy raised €620 million ($715 million) through the sale of 7.75 million shares of 10% Series A Perpetual Stream Preferred Stock at €80 per share, with settlement expected Nov. 13.This latest series of preferred stock, named STRE, or "stream," marks an expansion overseas in the company's fundraising efforts.MSTR's common shares continue to rapidly decline, lower by another 5% in early Friday trading alongside bitcoin's slide back to $100,000.Read full story
2025-11-07 16:27 4mo ago
2025-11-07 10:44 4mo ago
Bitcoin (BTC) Price Analysis for November 7 cryptonews
BTC
Cover image via U.Today

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

Bears are dominating on the last working day of the week, according to CoinStats.

Top coins by CoinStatsBTC/USDThe price of Bitcoin (BTC) has declined by 1.18% over the last 24 hours.

Image by TradingViewOn the hourly chart, the rate of BTC is in the middle of the local channel, between the support of $99,192 and the resistance of $102,463. 

You Might Also Like

As most of the daily ATR has passed, there are low chances of seeing sharp moves by the end of the day.

Image by TradingViewOn the longer time frame, the picture is also bearish. If the breakout of the support of $98,898 happens, the correction may continue to the $96,000-$98,000 zone until the end of the week.

Image by TradingViewFrom the midterm point of view, one should focus on the weekly candle's closure in terms of the $100,426 level. If the bar closes below that mark, traders may see an ongoing dump to the $90,000-$95,000 area.

Bitcoin is trading at $100,611 at press time.
2025-11-07 16:27 4mo ago
2025-11-07 10:44 4mo ago
Internet Computer Price Prediction: ICP Just Doubled in a Week – And the Smart Money Says It's Still Early cryptonews
ICP
Internet Computer price prediction has examined ICP's rapid run, with a 180% weekly gain, $1.31B in volume, and DFINITY's Caffeine upgrade. It has noted bullish sentiment, on-chain AI capacity, cycle burns, $7.20 support, and how a move over $10.50 could reopen $13–$15.
2025-11-07 16:27 4mo ago
2025-11-07 10:49 4mo ago
XLM Consolidates After Volatile Session Tests Key Support cryptonews
XLM
Recent price action shows institutional accumulation signals as volume surges 78% above average during resistance test. Nov 7, 2025, 3:49 p.m.

Market OverviewStellar (XLM) posted modest declines in a volatile 24-hour session ending Nov. 7 at 14:00. Prices dropped from $0.2705 to $0.2702 while trading within a tight $0.0109 range.

The session's critical development emerged at 12:00 UTC when 45 million tokens changed hands. This volume surge exceeded the 24 hour moving average of 25.4 million tokens by 78%. The spike confirmed resistance near $0.2777 while establishing solid support at $0.2663. These levels now frame institutional trading activity.

STORY CONTINUES BELOW

Without clear fundamental catalysts, technical levels dominated as institutional flows drove price action. Morning distribution patterns gave way to afternoon accumulation signals. The high-volume rejection at $0.2777 marked the session's turning point.

Volume concentration reveals institutional positioning strategies. Buyers accumulated 2.5 million tokens during the 13:20-13:22 advance. Another 1.5 million token spike occurred during the 14:07-14:09 rally. This coordinated buying reversed earlier bearish momentum and established new technical parameters for near-term trading.

XLM/USD (TradingView)

Key Technical Levels Signal Continuation Potential for XLMSupport/Resistance:

- Primary resistance established at $0.2777 (24-hour high)

- Intermediate resistance levels at $0.2690, $0.2700, and $0.2705 successfully cleared

- Strong support confirmed at $0.2663 during volume surge

- Broader range target identified at $0.2720-$0.2730

Volume Analysis:

- Peak institutional activity at 45.09M tokens (78% above 25.4M SMA)

- Accumulation signals in 13:20-13:22 window (2.5M tokens)

- Breakout confirmation during 14:07-14:09 spike (1.5M tokens)

Chart Patterns:

- Range-bound consolidation with $0.0109 total volatility

- Institutional distribution pattern followed by accumulation reversal

- Progressive resistance level clearing suggests continuation momentum

Targets & Risk/Reward:

- Immediate target zone: $0.2720-$0.2730 range

- Primary objective: Test of 24-hour high near $0.2777

- Key support maintained at $0.2663 for risk management

- Progression through resistance levels indicates potential for extended advance

Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy..

Higit pang Para sa Iyo

Inside Zcash: Encrypted Money at Planetary Scale

Nob 3, 2025

A deep dive into Zcash's zero-knowledge architecture, shielded transaction growth, and its path to becoming encrypted Bitcoin at scale.

Ano ang dapat malaman:

In 2025, Zcash evolved from niche privacy tech into a functioning encrypted-money network:

Shielded adoption surged, with 20–25% of circulating ZEC now held in encrypted addresses and 30% of transactions involving the shielded pool.The Zashi wallet made shielded transfers the default, pushing privacy from optional to standard practice.Project Tachyon, led by Sean Bowe, aims to boost throughput to thousands of private transactions per second.Zcash surpassed Monero in market share, becoming the largest privacy-focused cryptocurrency by capitalization.View Full Report

Higit pang Para sa Iyo

BNB Drops to Key Support Level Above $930 as Markets React to Liquidity Pressures

13 minuto ang nakalipas

BNB's ability to stay above its key $930 support may reflect confidence in the network's adoption, but a break above $975 could be needed to reopen the path toward recent highs.

Ano ang dapat malaman:

BNB's price slipped slightly over the last 24 hours, moving to $933 after briefly surging to $974.Despite market headwinds, BNB Chain saw 82 million active addresses in October, a new all-time high, and DEX volumes neared $120 billion.BNB's ability to stay above its key $930 support level may reflect confidence in the network's adoption, but a break above $975 could be needed to reopen the path toward recent highs.Basahin ang buong kwento
2025-11-07 16:27 4mo ago
2025-11-07 10:50 4mo ago
Crucial Bitcoin Bullish Metric Turns Positive, Imminent Rebound? cryptonews
BTC
Cover image via U.Today

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

The Bitcoin price is consolidating around $100,000 after days of experiencing price volatility. Amid the ongoing drawdown, analysts have spotlighted a key metric that has turned positive, potentially leading to a price reversal.

Bitcoin's Bid & Ask Ratio turns positiveMaartunn, a top analyst at CryptoQuant, noted that the Bitcoin Bid & Ask Ratio has flipped to +0.2. This is quite notable as it is the first green bar seen in months.

Typically, when the Bitcoin Bid & Ask Ratio turns positive, it suggests buy-side liquidity is accumulating the coin below the price. This is a signal of accumulation or strong buying interest.

The Bid & Ask Ratio is actually not a standard term. Rather, it refers to the bid-ask spread, which is the difference between the highest price a buyer is willing to pay (bid) and the lowest price a seller is willing to accept (ask).

Transactions take place when a buyer agrees to the ask price. Traders use the metric to calculate potential profit margins and assess the cost of executing trades.

However, the metric measures Bitcoin’s spot order books only within a tight price band around the current market price, typically 0-10% away.

The Bid & Ask Ratio ranges between -1 and +1. A positive reading means few asks, resulting in extreme buy pressure, while one fewer bid means strong sell pressure. However, if the metric reads zero, it is a perfect 50/50 balance.

Thus, a reading of +0.2 means bids outweigh asks by approximately 20% of the total liquidity in that near-price window. To put this in perspective in dollar terms, for every $100 of orders, approximately $60 are bids and about $40 are asks.

Implication for Bitcoin’s priceAs Maartunn explained, buy walls are forming, meaning aggressive buyers are stacking limit orders below the current price to defend it.

For most of 2025, the Bitcoin spot books were mostly asks. That kept a lid on rallies and made every dip feel heavy.

You Might Also Like

However, big players, including whales, institutions and market-makers, are now reloading bids. These investors are not chasing the price up but defending lower levels, preparing to absorb any sell-off.

Considering their actions, Bitcoin investors and traders can expect upside acceleration above $110,000 in the short term.

If the ratio stays green for longer, Bitcoin will likely enter a new impulsive phase. Previously, analyst PlanB targeted prices as high as $130,000 in the long term.
2025-11-07 16:27 4mo ago
2025-11-07 10:50 4mo ago
Strategy Upsizes Stream Stock to €620M to Fuel Bitcoin Buys cryptonews
BTC
TLDR:

Table of Contents

TLDR:Funds Target Bitcoin Acquisition and Corporate ExpansionDividend and Redemption Terms Outline a Long-Term StrategyGet 3 Free Stock Ebooks

Strategy expands its Stream Preferred Stock deal from €350M to €620M.
Funds will support Bitcoin purchases and general operations.
The STRE stock offers a 10% annual dividend, compounded if unpaid.
Settlement of the €620M offering is set for November 13, 2025.

Strategy Inc (Nasdaq: MSTR) announced the pricing of its €620 million Stream Perpetual Preferred Stock offering, expanding from an initial €350 million target. The company priced 7.75 million shares of its 10% Series A Stream Preferred Stock (STRE) at €80 per share. 

Settlement is scheduled for November 13, 2025, pending customary closing conditions. The firm expects net proceeds of about €608.8 million, according to its official release.

Funds Target Bitcoin Acquisition and Corporate Expansion
According to the company’s statement, proceeds from the offering will be used for general corporate purposes, including Bitcoin acquisitions and working capital. This move aligns with Strategy’s ongoing crypto investment strategy, widely associated with Michael Saylor’s continued focus on digital asset accumulation.

Based on Bloomberg’s €1.00/$1.1534 exchange rate, the proceeds equal roughly $715.1 million in gross capital raised.

The STRE Stock carries a 10% annual dividend rate, paid quarterly in arrears beginning December 31, 2025. Dividends will be distributed in cash when declared by the board, with compounded dividends applied to any unpaid amounts. 

The compounded rate can rise by 100 basis points per quarter if deferred, capped at 18% annually.

Dividend and Redemption Terms Outline a Long-Term Strategy
If Strategy fails to declare dividends by the record date, it will issue a notice of deferral and may sell other securities to cover missed payments. These may include the company’s Stride, Strike, or Strife preferred stock series, alongside other equity classes. The firm retains the right to redeem all outstanding STRE shares if their total falls below 25% of initial issuance or if certain tax events occur.

The redemption price equals the liquidation preference per share plus accrued dividends. The liquidation preference starts at €100 per share but can adjust daily based on trading activity or market pricing. Such flexibility allows the firm to maintain alignment with market value fluctuations.

Barclays, Morgan Stanley, Moelis & Company, SG Americas Securities, TD Securities, Canaccord Genuity, and StoneX Financial are acting as joint book-running managers for the offering. 

The company’s offering will not target retail investors within the European Economic Area or the U.K. Regulatory filings confirm that sales are restricted to professional and institutional investors under regional securities laws. The move ensures compliance with the Prospectus and PRIIPs regulations governing financial offerings in both markets.